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5-Aminoimidazole-4-carboxamide 1--D-ribofuranoside (AICAR,
or acadesine) is a precursor of the monophosphate derivative
5-amino-4-imidazole carboxamide ribonucleoside 5-phos-
phate (ZMP), an intermediate in de novo purine biosynthesis.
AICAR proved to have promising anti-proliferative properties,
although themolecular basis of its toxicity is poorly understood.
To exert cytotoxicity, AICAR needs to be metabolized, but the
AICAR-derived toxic metabolite was not identified. Here, we
show that ZMP is the major toxic derivative of AICAR in yeast
and establish that its metabolization to succinyl-ZMP, ZDP,
or ZTP (di- and triphosphate derivatives of AICAR) strongly
reduced its toxicity. Affinity chromatography identified 74 ZMP-
binding proteins, including 41 that were found neither as AMP
nor as AICAR or succinyl-ZMP binders. Overexpression of
karyopherin-Kap123, one of the ZMP-specific binders, partially
rescuedAICAR toxicity.Quantitative proteomic analyses revealed
57 proteins significantly less abundant on nuclei-enriched frac-
tions fromAICAR-fedcells, this effect being compensatedbyover-
expression ofKAP123 for 15 of them. These results reveal nuclear
protein trafficking as a function affected by AICAR.
AICAR6 is a naturalmetabolite that can be taken up by nucle-
oside transporters in human cells (1) and has multiple promis-
ing pharmacological properties (2). Indeed, AICAR has proved
in vivo anti-tumor effects in xenograft models (3–5). It is
currently under clinical trial phase I/II to treat patients with
chronic lymphocytic leukemia and has shown good safety and
tolerability properties, although some side effects have been
reported (6). Most of the described AICAR effects require its
metabolic conversion to the monophosphate form ZMP by
adenosine kinase (2). As an intermediate of the purine de novo
pathway, ZMP is naturally present in cells at low concentration
(7). ZMP and its precursor SZMP are important regulatory
molecules that promote interactions between specific tran-
scription factors and thereby directly couple the flux in the
purine de novo pathway to transcription of the genes encoding
the corresponding enzymes (8, 9). In addition, ZMP co-regu-
lates purine synthesis to phosphate utilization through its
interaction with common transcription factors (10). Strikingly,
the regulatory role of ZMP is conserved in bacteria, although
the riboswitch mechanism involved is totally different (11).
Although under physiological conditions ZMP is present in the
micromolar range (7), upon feeding of the riboside precursor
AICAR, ZMP concentration can increase to milli molar levels
(1), and, as a result, AICAR displayed cytotoxicity in yeast and
mammalian cells (2), although the exact mechanisms involved
are not known. The best documented pharmacological effect of
ZMP is activation of the low-energy sensorAMP-activated pro-
tein kinase (AMPK) (12, 13). This well-characterized effect was
attributed to theAMP-mimetic properties of ZMP (14) because
of the structural similarity of these nucleotides (see Fig. 1A).
However, the anti-proliferative effects of AICARwere shown to
be largely AMPK-independent (1, 15), thus implying that other
critical ZMP targets exist in the cell that have not yet been
identified.
Characterization of yeast mutants hypersensitive to AICAR
revealed its uptake by the nicotinamide riboside transporter
Nrt1 (see Fig. 1B) (1) and gave the first clues on the molecular
basis ofAICAR toxicity. Indeed, this approach establishedAICAR
transport, ATP homeostasis, histone methylation, and ubiquitin
metabolism as critical mechanisms underlying AICAR sensitivity
(1, 16–18). Importantly, someof thesemechanisms are conserved
from yeast to human cells (16, 17). However, in these chemoge-
netic studies based on synthetic lethality, neither the toxic deriva-
tive of AICAR nor its protein target(s) were identified. Aiming to
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unveil the identity of the toxic derivative, our previous work
established that intracellular AICAR and its succinyl-derivative
SAICAR,which are the riboside formsofZMPandSZMP, respec-
tively, were not toxic for yeast cells (7). This situation is reminis-
centofwhathappens inmammaliancells, inwhich thevastmajor-
ity of AICAR effects are abolished by adenosine kinase inhibitors
that block ZMP synthesis (19). Thus, for both yeast andmamma-
lian cells, it was concluded that AICAR riboside had to be meta-
bolically converted to the monophosphate form to become phar-
macologically active and cytotoxic. Understanding how small
molecules promote cytotoxicity is a complex task because small
molecules are frequently metabolized to derivatives that may
affect more than one biological process through interaction with
multiple targets. This led us to ask two essential questions. First, is
it ZMP itself and/or derivedmetabolites that are the toxic species?
Second, which proteins are affected by the toxic metabolite?
In this work, we addressed these questions by combining
yeast genetics, metabolic profiling, and proteomics to substan-
tiate the assumption that ZMP itself is the toxic compound for
yeast cells. Based on this result, we detected multiple ZMP-
binding proteins and identified nuclear trafficking as one of the
key functions affected by AICAR.
Results
AICAR treatment results in accumulation of ZMP, SZMP, and
ZTP
Effects of AICAR feeding on yeast cells were evaluated by
metabolic profiling of an ade16 ade17 ade8 his1 strain that is
unable to metabolize ZMP to IMP (20) (Fig. 1B). As previously
reported (1), in this genetic background, AICAR treatment
caused massive ZMP accumulation (Fig. 1C). In addition, met-
abolic profile analysis revealed that AICAR treatment resulted
in accumulation of SZMP, as well as of SAICAR, its riboside
form (Fig. 1C). This is because in yeast, ZMP can be converted
back to SZMP by adenylosuccinate lyase (Adsl), encoded by the
ADE13 gene (21) (Fig. 1B). In turn, SZMP is dephosphorylated
to SAICAR, which is nontoxic even at very high concentrations
in yeast (7). We also observed that AICAR feeding led to accu-
mulation of the triphosphate form, ZTP, whereas the diphos-
phate formZDPwas not detected (Fig. 1C). Finally, as expected,
AICAR itself accumulated in yeast cells (Fig. 1C), but intracel-
lular accumulation of this compound was previously demon-
strated to be nontoxic (7).
Thus, AICAR treatment resulted in accumulation of ZMP,
SZMP, and ZTP that could potentially affect cellular functions
and result in toxicity.We thus used yeast genetics to identify the
toxic derivative(s) of AICAR.
SZMP synthesis is not required for AICAR toxicity
We first asked whether SZMP could contribute to AICAR
toxicity. The ade13 knockoutmutation blocking SZMP synthe-
sis from ZMP (Fig. 1B) was introduced in an ade16 ade17 ade8
his1 strain, and the resulting quintuple mutant strain was
found to be highly sensitive to AICAR (Fig. 2A). As expected,
the ade13 mutation abolished SZMP accumulation, whereas
intracellular ZMPwas higher than in the control strain (Fig. 2,B
andC).We conclude that AICAR toxicity was not due to SZMP
synthesis from ZMP but correlated with intracellular ZMP
accumulation. These conclusions were strongly supported by
analysis of a fumarase knockout mutant fum1, which accumu-
lates fumarate (Fig. 2D) and thereby favors the reverse reaction
from ZMP to SZMP by adenylosuccinate lyase Adsl (Ade13)
(Fig. 1B), leading to increased SZMP and decreased ZMP levels
(Fig. 2, E and F). In the corresponding mutant strain (fum1
ade16 ade17 ade8 his1), AICAR toxicity was abolished (Fig.
2G). From these results, we conclude that, in yeast, SZMP is not
the metabolite that causes AICAR toxicity, but synthesis of
SZMP rather contributes to its detoxification.
ZDP and ZTP are not toxic for yeast cells
To get a deeper insight into the mechanisms leading to
AICAR toxicity, we performed an unbiased search for genes
that suppress AICAR toxicity when overexpressed. A yeast
Figure 1. AICAR feeding of yeast cells results in accumulation of several
AICAR-derived metabolites. A, chemical structure of ZMP and AMP deriva-
tives. B,Adsl, adenylosuccinate lyase;Atic, AICAR transformylase IMP-cyclohy-
drolase; FAICAR, 5-formamido-4-imidazole carboxamide ribonucleoside
5-phosphate; PRPP, 5-phosphoribosyl-1-pyrophosphate. Only the enzymes
mentioned in the text are listed (in gray).Questionmarks correspond to enzy-
matic activities catalyzed by unidentified proteins prior to this work. C, accu-
mulation of AICAR derivatives in yeast (ade8 ade16 ade17 his1; Y2950) fed
(blue lines) or not (black lines) for 24 h with extracellular AICAR. Similar pat-
terns were found in three independent metabolic extractions. Insets corre-
spond to enlargement of chromatogram sections where AICAR and SAICAR
derivatives were eluted.
AICARmonophosphate toxicity
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genomic library carried on a multicopy vector was used to
search for gene dosage suppressors of AICAR sensitivity in a
yeast strain that can accumulate ZMP and derivatives when
the riboside is provided (see “Experimental procedures” for
details). The suppressor plasmids all carried an overlapping
DNA region of chromosome XI containing four genes: two
genes of unknown function (YKL023C-A and YKL023W),
PAN3 encoding a subunit of the Pan2p-Pan3p poly(A)-RNase
complex, and URA6, an essential gene encoding UMP kinase,
which was reported to have significant AMP kinase activity
(22). Of note,URA6was previously identified as a suppressor of
AICAR sensitivity hypomorphic allele of UBA1 but was not
further characterized (18). Because ZMP is structurally close
to AMP (Fig. 1A), we hypothesized that Ura6 could phosphor-
ylate ZMP and thereby improve growth upon AICAR feeding.
Indeed, overexpression of URA6 alone was sufficient to confer
robust resistance to AICAR similarly to the initial suppressor
plasmid (Fig. 3A). Metabolic profiling on yeast cells grown in
the presence of AICAR revealed that overexpression of URA6
resulted in accumulation of ZDP and ZTP, both of which are
hardly detectable in the control strain (Fig. 3, B and C). Notice-
ably, in the AICAR-resistant strain overexpressingURA6, ZMP
was lower (Fig. 3D), whereas both ZDP and ZTP levels were
higher than in the AICAR-sensitive control strain (Fig. 3, B and
C). We conclude that ZMP, rather than its di- or triphosphate
derivatives, is the toxic metabolite derived from AICAR.
Accordingly, AICAR feeding had no effect onmutation rates in
yeast (Fig. S1A) even under conditions (URA6 overexpression)
resulting in high ZTP levels (Fig. S1B). Similarly, AICAR feed-
ing did not affect other aspects of DNA metabolism such as
mitotic recombination rate (Fig. S2) or telomere length (Fig.
S3). Together, these results establish that AICAR toxicity is not
associated with ZTP synthesis.
Notably, recombinant yeast Ura6 purified from Esche-
richia coli (Fig. 3E) could synthesize ZDP, but not ZTP, from
ZMP in vitro (Fig. 3, F–H), as expected for a nucleoside
monophosphate kinase. However, both ZTP and ZDP were
found as reaction products when the reaction was run with
total extracts from URA6-expressing bacteria (Fig. 3, G and
H). Altogether, these results show that Ura6 can synthesize
ZDP fromZMPand that another enzyme(s) can further phos-
phorylate it to ZTP in both yeast and bacteria. We estab-
lished that yeast NDP-kinase Ynk1 was not required because
ynk1 knockout had no effect on ZTP production (Fig. S4). Of
note, purified yeast adenylate kinase Adk1, which was not
found in the gene-dosage suppressor screening had no
detectable ZMP-kinase activity in vitro.
Thus, our genetic and biochemical experiments in yeast
demonstrate that ZMP, rather than SZMP, ZDP, or ZTP, is the
toxic molecule derived fromAICAR. The question arising then
was: why is ZMP toxic?
Proteome-wide identification of ZMP binders
To identify potential effectors of ZMP toxicity, we isolated
yeast proteins that interact with ZMP by an affinity chroma-
tography approach (for details, see “Experimental proce-
dures” and Ref. 10). Whole-cell protein extracts from six
independent cultures were loaded on a ZMP-Sepharose
resin. The eluted proteins (herein called ZMP binders) were
identified by MS. A total of 74 proteins, representing 1.1%
of the yeast proteome, were identified by at least two differ-
ent peptides in at least four of six experiments (Fig. 4A and
Table S1). Among them was the enzyme adenylosuccinate
lyase (Ade13), a known ZMP binder (10), synthesizing ZMP
from SZMP. However, identification of ZMP binders by this
approach was not exhaustive because other ZMP-metaboliz-
Figure 2. SZMP is not required for AICAR toxicity but rather contributes to its detoxification in yeast. A–C, deletion of the ADE13 gene leads to
increased ZMP accumulation and AICAR toxicity. A, yeast strains (Y2950 and Y10422) were grown overnight, serially diluted (1/10), and spotted on
SDcasaWAU medium containing or lacking AICAR. The plates were imaged after 48 h of incubation at 30 °C. B and C, ZMP (B) and SZMP (C) relative
content was determined on metabolic extracts from three independent cell cultures of each strain (Y2950 and Y10422) grown in SDcasaWAU medium
and treated with AICAR (0.5 mM) for 24 h. Relative contents were set at 1 for the ADE13 control strain. D–G, favoring SZMP synthesis from ZMP lowers
AICAR toxicity. D–F, metabolic analyses were done on three independent extractions from cells (Y2950 and Y3655) grown in SDcasaWAU medium and
treated with AICAR (0.5 mM, 24 h). Relative content was set at 1 for the FUM1 control strain (Y2950). G, AICAR resistance was increased in a FUM1-deleted
strain (Y3655) grown for 48 h in SDcasaWAU medium at 30 °C. B–F, errors bars and statistics correspond to standard deviation and Welch’s unpaired t
tests. **, p  0.01; ***, p  0.001; ****, p  0.0001; UD, undetectable.
AICARmonophosphate toxicity
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ing enzymes (Ade16, Ade17, or Ura6) or previously identi-
fied binders (Pho2 or Pho4 (10)) were not found. Most inter-
estingly, the ubiquitin-activating enzyme Uba1 was found as
a ZMP binder, suggesting that it could be a direct target for
ZMP and account for reported chemo-genetic effects of
AICAR on the ubiquitin pathway (18). Analysis of the bio-
logical processes (Gene Ontology (GO) terms), associated
with the proteins retained on the ZMP resin, showed a
strong enrichment in purine nucleotide binding, unfolded
protein binding, and translation factor activity (Fig. 4B). The
best score was for “purine nucleotide binding” (p value 2.7 
109), thus validating the affinity chromatography approach
because ZMP is a precursor of purine nucleotides.
To evaluate the specificity of ZMP-binding proteins, a simi-
lar approach was applied to closely related molecules, namely
AMP, SZMP, and AICAR. A list of proteins retained on AMP,
Figure3.TheUMPkinaseUra6promotesZMPphosphorylation inyeast.A, overexpressionof theURA6gene strongly reducesZMP toxicity. Theade3ade16
ade17 ade8 his1 strain (Y8908) was transformed with either the suppressor plasmid isolated during the genetic screen (suppressor, P4979), a plasmid overex-
pressing URA6 gene (P4919), or the cognate empty vector as control (control; YEplac195). Transformants were grown overnight, serially diluted, and spotted
on SDCasaWA medium containing, or lacking, AICAR. The plates were imaged after 2 days at 30 °C. B–D, effect of URA6 overexpression (p4919) on relative
content ofAICARderivatives in theade3ade8ade16ade17his1 strain (Y8908).Quantificationsofmetaboliteswereobtained from four independent extractions
for each condition on strains grown in SDcasaWAmedium for 24 h in the presence of 0.5 mM AICAR. Standard deviations are presented. Statistics correspond
to Welch’s t tests. ***, p 0.001; ****, p 0.0001. E–H, purified Ura6 (E) catalyzes ZDP, but not ZTP, synthesis in vitro. F–H, ZMP, ZDP, and ZTP were measured
after a 15-min incubation at 30 °C with ZMP (1 mM) and ATP (2 mM) and His6–Ura6 either in total protein bacterial (Bact.) extracts or purified (E). Metabolite
amounts were set at 1 for the amounts measured with bacterial extracts containing the empty vector (control). Errors correspond to standard deviation
obtained from six independent measurements.
AICARmonophosphate toxicity
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SZMP, and AICAR resins is presented in Table S1, revealing
enrichment for specific functions. The best scores for SZMP
and AICAR corresponded to “structural constituent of the
ribosome,” whereas for AMP it was “nucleotide binding” (Fig.
S5). Among the 74 ZMP binders, 30 bound at least another
compound tested (Fig. 4A). Interestingly, only eight proteins
were found exclusively on ZMP and AMP columns, a binding
pattern that would be expected for proteins echoing the AMP-
mimetic effects of ZMP described for AMPK. Of note, the 
subunit of yeast AMPK (Snf4) was not retained on the columns
as expected because yeast AMPK was found to be activated by
ADP rather than AMP (23). Accordingly, a snf4mutant did not
show altered AICAR sensitivity (Fig. S6). Among the 74 ZMP
binders, 44 were exclusive ZMP binders, strongly suggesting
that ZMPeffects aremost likely not restricted toAMPmimicry.
Overexpression of ZMP binders reveals nuclear trafficking as a
function affected by AICAR
We reasoned that themost likely effectors of ZMP toxicity in
vivo are proteins that bind ZMP (and also possibly AMP) but
not the nontoxic derivatives SZMP and AICAR. The genes
encoding 44 such yeast proteins (highlighted in yellow in Fig.
4A) were overexpressed from multicopy plasmids, and their
ability to affect resistance toAICAR in yeast cells was evaluated.
These 44 proteins comprised 36 of the 44 exclusive ZMP bind-
ers, and all the 8 AMP/ZMP exclusive binders. Overexpression
of most of these genes, including UBA1, had no or little effect
(Fig. S7), but overexpression of KAP123 clearly improved the
ability to grow in the presence of AICAR, asURA6 did (Fig. 5A).
However, in contrast to URA6, overexpression of KAP123 did
Figure 4. Proteome-wide identification of yeast ZMP binders by affin-
ity chromatography. A, list of ZMP binders found at least four times in six
affinity-chromatography experiments performed with independent sam-
ples. Proteins also found on other affinity resins are indicated. Complete
lists are shown in Table S1. Genes highlighted in yellow were overex-
pressed, and their effects on AICAR sensitivity are shown in Fig. S7. B,
biological process GO terms enrichment analysis for the 74 ZMP binders
(http://www.geneontology.org/; please note that the JBC is not responsi-
ble for the long-term archiving and maintenance of this site or any other
third party hosted site) (34, 35).
Figure 5. Overexpression of KAP123 enhances AICAR resistancewithout
changingZMP intracellular content.A, cells (ade8 ade16 ade17 his1; Y2950)
were transformedwith plasmids allowing overexpression (OE) of eitherURA6
(p4919) or KAP123 (p4983) or with the empty vector (YepLac195, none).
Transformants were serially diluted and spotted on SDcasaWAmedium. The
plates were imaged after 2 days at 37 °C. B, ZMP relative content was deter-
mined on seven independent transformants from Fig. 5A and exponentially
grown in SDcasaWAmedium for 24 h in the presence of AICAR (3 mM). Errors
bars and statistics correspond to standard deviation and Welch’s t test. NS,
nonsignificant; ***, p 0.001. C, specific binding of Myc-tagged Kap123 and
Uba1 proteins to the ZMP-affinity resin was confirmed by Western blotting.
FT, flow through. Elution corresponds to the fraction elutedwith the cognate
specific nucleotide (5 mM) on each affinity resin.
AICARmonophosphate toxicity
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not lower intracellular ZMP (Fig. 5B), as expected for a ZMP
target.
We then confirmed the binding to ZMP of Kap123 (but also
Uba1; see “Proteome-wide identification of ZMP binders”),
using epitope-tagged versions of the proteins. Indeed, both
Kap123 andUba1 proteins were retained on the ZMP resin, but
not on the AMP resin, as revealed byWestern blotting analysis
(Fig. 5C). In this experiment, Ade13 (adenylosuccinate lyase)
and Apt1 (adenine phosphoribosyltransferase), for which ZMP
and AMP are the corresponding reaction products, were used
as positive controls for the ZMP and AMP resin, respectively
(Fig. 5C). Aah1 (adenine deaminase) was used as a negative
control for both resins (Fig. 5C).
Because Kap123 is an importin mediating the nuclear traf-
ficking of several cargoes, including ribosomal proteins (24),
we hypothesized that ZMP could affect nuclear transport.
We first monitored nuclear localization of the Rpl25–NLS–
GFP fusion (ribosomal 60S subunit protein L25 fused to
green fluorescent protein via a nuclear localization signal),
which is fully dependent on Kap123 (24). We found that it
was not affected by AICAR (Fig. S8), indicating that AICAR
does not primarily act through inhibition of Kap123, although
overexpression of Kap123 can clearly bypass defects associated
with AICAR treatment. The effect of AICAR on nuclear traf-
ficking was then directly and globally assayed by comparing
protein composition of nuclei-enriched extracts from yeast
treated or not treated with AICAR by label-free quantitative
analysis. Strikingly, 57 proteins were significantly less abundant
(at least 2-fold) in the nuclei-enriched fraction following
AICAR treatment (Fig. 6A and Table S2). Among these 57 pro-
teins, 17 (highlighted in yellow in Table S2) were also detected
in whole cell protein extracts by quantitative MS, and in all
cases their abundance was not significantly changed in
response to AICAR. We conclude that AICAR affects their
nuclear localization rather than their overall abundance. GO-
term analysis revealed that, among these 57 proteins, nuclear
components and nuclear functions such as chromatin assembly
and organization, rRNA metabolism, or transcription, were
most significantly over-represented (Table S3).
A parallel analysis, performed on yeast cells grown in the
presence of AICAR and overexpressing or not KAP123,
revealed 92 proteins that were significantly more abundant
in the nuclei-enriched fraction when KAP123 was overex-
pressed (Table S4). Among those, proteins involved in chro-
matin and transcription-related processes were very signifi-
cantly over-represented (Table S5). Most conspicuously, 15
proteins, less abundant in the nuclei-enriched fraction fol-
lowing AICAR treatment, were “restored” whenKAP123was
overexpressed (Fig. 6B). This overlap is statistically highly
significant (hypergeometric distribution: p  2.16  105),
pointing to a strong functional connection between AICAR
feeding and KAP123 overexpression. Again, proteins involved in
chromatin organization and transcription were overrepresented
among these 15 proteins (Fig. 6C). This result shows thatKAP123
overexpression can compensate for some of the effects that
AICARexertsonnuclear traffic andcould in thiswaycontribute to
the suppression of AICAR-induced phenotypic effects. Taken
together, these results revealnuclear traffickingasacritical cellular
function that is altered by AICAR and point to Kap123 as an
important, although nonexclusive, effector protein.
Specificity of KAP123 and URA6 as dosage suppressors
In previous work, we identified several mutants that showed
high sensitivity to AICAR because of increased uptake and
accumulation (thi3, pdc2, and thi80 mutant strains) (1);
impaired purine metabolism (aah1, ade13, and hpt1) (17); or
interference with cell cycle progression (bre1, rad6, set1, and
swd1) (16). Representative mutants among those were assayed
to establish whether they could be phenotypically suppressed
byURA6 orKAP123 overexpression. In fact,URA6 overexpres-
sion efficiently suppressed AICAR sensitivity of the set1 and
thi3mutants (Fig. 7, A and B) and had a weaker but reproduc-
ible effect on the aah1 mutant (Fig. 7C). By contrast, overex-
pression of KAP123 only rescued AICAR sensitivity of the set1
mutant (Fig. 7A) and not that of other mutants such as thi3 or
aah1 (Fig. 7, B and C), indicating that increased sensitivity of
the various mutants has distinct causes. Consistent with our
previous findings (16), other mutants in the set1 pathway (bre1,
swd1, and swd3) were also suppressed by KAP123 overexpres-
sion (Fig. S9). Overall, these results point to a central role for
nuclear trafficking inAICAR sensitivity of yeastmutants affect-
ing cell-cycle progression.
Discussion
The purine biosynthesis metabolic intermediate ZMP is nat-
urally present in eukaryotic cells at low concentration. It can
Figure 6. Nuclear protein content is altered by AICAR treatment in
yeast. A, Venn diagram representation for proteins less abundant in the
nuclei-enriched fraction after AICAR treatment (green circle) and proteins
more abundant in nuclei-enriched fraction of cells overexpressing KAP123
in the presence of AICAR (gray circle). The entire lists of proteins that sig-
nificantly changed in both conditions are presented in Tables S3 and S4. B,
list of the 15 common proteins in the Venn diagrampresented in Fig. 6A. C,
GO term analysis (http://www.geneontology.org/; please note that the
JBC is not responsible for the long-term archiving andmaintenance of this
site or any other third party hosted site) (34, 35)8 for the 15 proteins listed
in Fig. 6B.
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accumulate when its riboside precursor AICAR is provided to
the cell, but also in several metabolic diseases. Indeed, ZMP
as well as ZDP and ZTPwere found at very high concentrations
(ZTP reaching even higher levels than ATP) in red blood cells
of an AICAR transformylase IMP-cyclohydrolase–deficient
patient lacking the enzyme that catalyzes the last two steps of
the purine biosynthesis pathway (25) and was the best marker
for hypoxanthine-guanine phospho-ribosyl-transferase defi-
ciency in a large cohort of Lesch–Nyhan syndrome patients
(26). The precise role of ZMP in the etiology of these diseases is
unclear but should be addressed in connection with the fact
that treating eukaryotic cells withAICAR at high concentration
is toxic. In many studies, it was shown that the riboside precur-
sor of ZMPhadno biological effects, suggesting that ZMP itself,
or a derivative, is the active compound. In our study, taking
advantage of the power of yeast genetics, we established that
AICAR toxicity tightly correlateswithZMPaccumulation; low-
ering ZMP accumulation by stimulating its conversion to
SZMP, ZDP, or ZTP derivatives decreased toxicity of the pro-
drug AICAR. Thus, increasing the levels of intracellular ZTP
did not enhance toxicity of AICAR but rather decreased it. This
suggests that AICAR toxicity is not due to massive incorpora-
tion of AICAR-nucleotides into nucleic acids. Accordingly, we
found no effect of AICAR on mutation or recombination rate,
as well as telomere length. These results are consistent with
those obtained in previous work showing that yeast mutants
displaying increased AICAR uptake became hypersensitive to
this compound and that the sensitivity was associated with a
10-fold increase of the monophosphate (ZMP) concentration
(1), whereas the di- and triphosphate forms (ZDP and ZTP)
were hardly detectable.7Altogether, these results reveal ZMPas
the toxic compound in yeast cells treated with the prodrug
AICAR.
Affinity chromatography allowed us to identify a spectrumof
AMP- and ZMP-binding proteins from yeast, thus providing a
new resource of nucleotide-binding proteins. Only 20 of the 81
AMP binders and 74 ZMP binders were retained on both AMP
and ZMP resins, indicating that not all AMP binders are able to
efficiently bind ZMPdespite its well-establishedAMP-mimetic
role best exemplified as an effector molecule acting on mam-
malian AMP-activated kinase (14). Symmetrically, most ZMP
binders were not identified as AMP binders.Why do these pro-
teins bind ZMP? It is possible that some of the identified pro-
teins physiologically bind ZMP, as Ade13 does? It could also
be that ZMP binding imitates physiological interaction of these
proteins with another nucleotide. In any case, our results
strongly suggest that some of the AICAR effects are not due to
AMP-mimetic interactions of ZMP with target proteins. Thus,
our data support the view that the toxic effects of ZMP are not
due to its AMP-mimetic properties.
Overexpression of KAP123, which has been identified as an
“exclusive ZMP binder,” significantly improved AICAR resis-
tance, and this effect was enhanced in bre1, set1, swd1, and
swd3 AICAR-sensitive mutants affecting histone methylation.
Kap123 is a karyopherin- involved in the nuclear entry ofmul-
tiple proteins including ribosomal proteins and histones (24,
27). Strikingly, Srm1, the guanyl-nucleotide exchange factor for
yeast Ran Gsp1p, was among the 57 proteins for which nuclear
localizationwas impaired byAICAR.This protein, homologous
to human RCC1, is critical for nuclear trafficking, and its mis-
localization uponAICAR treatment could, in a cascading effect,
contribute to mislocalization of several other proteins. Thus,
these results point to AICAR affecting nuclear trafficking in a
way that is at least partly Kap123-dependent.
Suppression of bre1, set1, and swd1 by Kap123 overexpres-
sion confirmed that nuclear trafficking contributes to the
chemo-genetic effect of AICAR in several histone modification
mutants, as proposed previously (16). It should be stressed that
KAP123 overexpression only partially suppressed AICAR sen-
sitivity and was not a suppressor of all AICAR-sensitive
mutants (Fig. 7), implying that some AICAR effects most prob-
ably involve targets other than Kap123. Indeed, we had previ-
ously identified the ubiquitin pathway as an important target
for ZMP toxicity (18), and remarkably, unfolded protein bind-
ing was the second enriched GO term among the ZMP binders
(Fig. 4). In this work, Uba1, the ubiquitin-activating enzyme at
the apex of the ubiquitin pathway, was identified as a ZMP
binder, suggesting that it could be a direct target of ZMP. How-
ever, overexpression of UBA1 alone was not sufficient to
increase the ability of yeast cells to cope with AICAR (Fig. S7),
revealing a rather complex situation, as previously highlighted
by our genetic analyses (18). Even at the level of nuclear traf-
ficking, our finding of a partial overlap between KAP123 over-
7 J. Ceschin, B. Daignan-Fornier, and B. Pinson, unpublished results.
Figure 7. AICAR toxicity is alleviated by KAP123 overexpression specifi-
cally in the AICAR-sensitive set1 mutant affected in cell cycle progres-
sion. A–C, effect of URA6 and KAP123 overexpression on growth of AICAR-
sensitive strains affected in cell-cycle progression (A), in AICARuptake (B), and
in purine metabolism (C). Mutant strains (Y9168, Y7321, and Y10846) were
transformed with the empty plasmid (YepLac195, none) or with plasmids
allowing overexpression (OE) of either URA6 (p4919) or KAP123 (p4983).
Transformants were serially diluted and spotted on SDcasaWA medium 
AICAR (A and B) or SDcasaW medium supplemented with either hypoxan-
thine or adenine (C). The plates were imaged after 3 days at 37 °C.
AICARmonophosphate toxicity
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expression and AICAR effect on nuclear protein content sug-
gests a complex interplay between ZMP and the nuclear
trafficking machinery involving additional players. One such
candidate is Yrb1, a Ran GTPase-binding protein involved in
nuclear protein trafficking that was identified as one of the
ZMP-specific binders in this work. However, overexpression of
YRB1 had no major effect on growth in the presence of AICAR
(Fig. S7).
This study illustrates that a molecule with anti-proliferative
properties interacts withmultiple proteins and, even on a single
process such as nuclear trafficking, most probably acts through
more than one effector. The polypharmacology paradigm pro-
posed 10 years ago (28) underlines how combined effects of a
drug on multiple targets can bypass phenotypic robustness
while limiting toxicity. Importantly, acadesine (AICAR) was
well-tolerated in clinical trials (6) and was found pharmacolog-
ically active in several animal-model studies (3–5, 15, 29).
Understanding the diverse molecular bases of AICAR effects
will give clues to its beneficial and adverse effects and could
permit synthetic-lethality predictions, smart development of
derived compounds, and drug repurposing (30).
Experimental procedures
Yeastmedia, yeast strains, and plasmids
SD is a synthetic minimal medium containing 0.5% ammo-
nium sulfate, 0.17% yeast nitrogen base (BD-Difco, Franklin
Lakes, NJ), 2% glucose. SDcasaW is SD medium supplemented
with 0.2% casamino acids (catalog no. 233520; BD-Difco) and
tryptophan (0.2 mM). When indicated, adenine (0.3 mM),
hypoxanthine (0.3 mM), and/or uracil (0.3 mM) were added in
SDcasaW medium, resulting in media termed SDcasaWA (	
adenine), SDcasaWHypox (	 hypoxanthine), SDcasaWU (	
uracil), and SDcasaWAU (	 adenine 	 uracil). Yeast strains
are listed in Table S6 and belong to, or are derived from, a set of
knockout mutant strains isogenic to BY4742 purchased from
Euroscarf (Frankfurt, Germany). Multimutant strains were
obtained by crossing, sporulation, and micromanipulation of
meiosis progeny. The plasmids used in this study are described
in Table S7. Cloning details for the unpublished plasmids are
available upon request.
Yeast growth test
Yeast cells were resuspended in sterile water to 2  107
cells/ml and subjected to 1/10 serial dilutions. Drops (5 l) of
each dilution were spotted on freshly prepared plates and were
incubated at indicated temperature for 48–72 h.
Isolation ofmulticopy suppressors of AICAR toxicity
To obtain multicopy suppressors of AICAR toxicity, an ade3
ade16 ade17 ade8 his1 strain (Y8908) was used because in such
a strain both ade3 and ade16 ade17 mutations block AICAR
transformylase IMP-cyclohydrolase activity and therefore nei-
therADE3,ADE16, norADE17 can be selected as a suppressor.
This strain was transformed with a multicopy plasmid library
(PFL44L backbone, generous gift from F. Lacroute), and trans-
formants were selected on SDcasaWA medium after 48 h of
incubation at 30 °C. The colonies were then transferred by rep-
lica plating on the same medium containing 5 mM AICAR and
grown for 48 h at 37 °C. This screening temperaturewas chosen
because in previous work we noticed that addition of AICAR
was much more toxic for yeast cells at 37 °C than at 30 °C (1).
Multicopy plasmidswere extracted from six clones able to grow
in the presence of AICAR and were sequenced. These plasmids
contained a DNA fragment from the same region of chromo-
some 11. The plasmid (p4979) containing the 4.6-kbp fragment
with chromosome coordinates 390,252–394,835 bpwas further
studied (see “Results”).
Metabolite extraction from yeast cells and separation by LC
Extraction of metabolites was performed in an ethanol with
10mMHEPES, pH 7.2 (3/1), solution for 3min at 80 °C for yeast
as described (1). The extracts were then evaporated using a
rotary evaporator (8 min, 65 °C), and the dried residues were
resuspended inMilliQ water. Insoluble particles were removed
by centrifugation (21,000 g, 4 °C; 1 h). Metabolites were then
separated on an ICS3000 chromatography station (Dionex,
Sunnyvale, CA) using a carbopac PA1 column (250  2 mm;
catalog no. 057178; Thermo Fisher Scientific) with a 0.25
ml/min flow rate. Elution of metabolites was achieved with a
sodium acetate gradient in 50mMNaOHas follows: elutionwas
started at 50mM sodium acetate for 2min, rising up to 75mM in
8 min, then to 100 mM in 25 min, and finally to 350 mM in 30
min, followed by a step at 350mM for 5min, rising to 500mM in
10min, and being kept at this sodium acetate concentration for
5 min, and finally raised to 800 mMwithin 10 min followed by a
step at this concentration for 20 min. The resin was then equil-
ibrated at 50 mM sodium acetate for 15 min before injection of
a new sample. The peaks were identified by their retention time
and their UV spectrum signature (Diode Array Detector Ulti-
mate 3000 RS; Dionex), and when necessary by co-injection
with standards. For each strain analyzed, normalization to cel-
lular volume was done with a Multisizer 4 (Beckman Coulter).
Peak quantifications were done at the following wavelengths:
230 nm for fumarate, 260 nm for ATP, and 269 nm for AICAR,
SAICAR, ZMP, and SZMP. All metabolite extractions were
performed on at least three to six independent yeast cell
cultures.
Affinity chromatography
ZMP-binding proteins were identified by affinity chroma-
tography using the ZMP-Sepharose resin described previously
(10). Protein extracts were prepared from the BY4742 WT
strain as described (10), except that elution of the ZMP binders
was performedwith ZMP (5mM; catalog no. A611705; Toronto
Research Chemicals) in buffer A (Na2HPO4/HCl, pH 7.2, 10
mM NaCl). Elution fractions were concentrated on a Nanosep
10K Omega filter, and protein concentration was measured.
The ZMP binders were then identified using MS according
to the procedure described in protein identification by LC-
MS/MS and database search and results processing sections. A
stringent cutoff was then applied, retaining only proteins iden-
tified with at least two peptides, and found at least four times in
six independent experiments (Table S1). The ability of proteins
to bind AMP, SZMP, or AICAR was also assayed using either a
commercial AMP-agarose resin (catalog no. A1271; Merck) or
AICARmonophosphate toxicity
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SZMP- and AICAR-resins prepared as described for the ZMP
resin (10). In each case, elution of interacting proteins was per-
formed with 5 mM of the corresponding metabolite (AMP (cat-
alog no. A1752; Merck), SZMP (lab collection, (8)), or AICAR
(catalog no. A611700; Toronto Research Chemicals)) dissolved
in buffer A.
Immunoblot
Western blots were hybridized with the following anti-
bodies: anti-Myc (1/5,000; catalog no. MMS-150R; Covance),
anti-Ade13 (1/15,000 (8)), anti-HA (1/10,000, catalog no.
H9658; Sigma–Aldrich), and anti-Aah1 (1/10,000 (31)).
Protein identification by LC-MS/MS
Concentrated proteins from each affinity-chromatography
elution fractionswere solubilized in Laemmli sample buffer and
subjected to SDS-PAGE to evaluate concentration and for
cleaning purposes. After entering the resolving gel, separation
was stopped. Following colloidal blue staining, the bands were
cut out from the SDS-PAGE gel and subsequently cut into 1
1 mm gel pieces. Gel pieces were destained in 25 mmol/liter
ammonium bicarbonate 50% (w/v), rinsed twice in ultrapure
water, and shrunk in acetonitrile for 10 min. After acetonitrile
removal, gel pieces were dried at room temperature, covered
with trypsin solution (10 ng/l in 40 mM NH4HCO3 and 10%
acetonitrile), rehydrated at 4 °C for 10 min, and finally incu-
bated overnight at 37 °C. Gel pieces were then incubated for 15
min in 40mMNH4HCO3 and 10% acetonitrile at room temper-
ature on a rotary shaker. The supernatant was collected, and an
extraction solution (H2O, acetonitrile, HCOOH (47.5/47.5/5))
was added to the gel slices for 15 min. This extraction step was
repeated twice. Supernatants were pooled and concentrated
with a vacuum centrifuge to a final volume of 25 l. Digests
were finally acidified by addition of 1.5 l of formic acid (5%,
v/v) and stored at20 °C. The peptidemixturewas analyzed on
an Ultimate 3000 nano-LC system (Dionex) coupled to either a
LTQ, a LTQ-Orbitrap XL, or a Q-Exactive mass spectrometer
(ThermoFinnigan, San Jose, CA). In all cases, 10 l of peptide
digests were loaded onto a C18 PepMapTM trap column (300-
m; 5-mmLCPackings) at a 30l/min flow rate. Peptides were
eluted from the trap column and then loaded onto an analytical
C18 Pep-Map column (75 mm  15 cm; LC Packings) for 105
min with a 5–40% linear gradient of 80% acetonitrile with 0.1%
formic acid in 5% acetonitrile with 0.1% formic acid at a 200
nl/min flow rate. The mass spectrometer operated in positive
ion mode at a 1.8–2-kV needle voltage. Mass spectrometry
acquisition parameters are given in Table S8.
Nuclei-enriched fractions preparation and label-free
quantitative data analysis
Yeast cells (ade16 ade17 ade8 his1; Y8480) were transformed
by the plasmid allowing KAP123 overexpression or by the cog-
nate empty vector serving as negative control. Transformants
exponentially grown in SDcasaWAwere treated with 0 or 1mM
AICAR for 2 h. The cells were collected and used to prepare
total protein extracts and in parallel to perform nuclei enrich-
ment with a commercial kit (Abnova catalog no. KA3951). For
each condition, the experiments were done in triplicate with
samples obtained from independent cultures. LC-MS/MS data
were acquired on a Q-Exactive mass spectrometer as described
above and were subsequently imported in Progenesis LC-MS
4.0 (Non Linear Dynamics). Data processing included the fol-
lowing steps: (i) features detection, (ii) features alignment
across the LC-MS/MS runs, (iii) volume integration for 2–6
charge-state ions, (iv) normalization on feature median ratio,
(v) import of sequence information, (vi) analysis of variance test
at peptide level and filtering for features (p 0.05), (vii) calcu-
lation of protein abundance (sum of the volume of correspond-
ing peptides), and (viii) analysis of variance test at protein level
and filtering for features (p  0.05). Proteins were grouped
according to the parsimony principle so as to establish themin-
imal protein list covering all detected peptides. Noticeably, only
nonconflicting features and unique peptides were considered
for calculation at protein level. Quantitative data were consid-
ered for proteins quantified by a minimum of two peptides.
Database search and processing of proteomic results
The data were searched by SEQUEST through Proteome
Discoverer 1.4 (Thermo Fisher Scientific Inc.) against the Sac-
charomyces cerevisiae Reference Proteome Set (Uniprot 2015-
05; 6636 entries). Spectra frompeptides higher than 5,000Da or
lower than 350 Da were rejected. The search parameters were
as follows: mass accuracy of the monoisotopic peptide precur-
sor and peptide fragments were as described in Table S8. Only
b- and y-ions were considered for mass calculation. Oxidation
of methionine (	16 Da) was considered as variable modifica-
tion. Two missed trypsin cleavages were allowed. Peptide vali-
dationwas performed using Percolator algorithm (32), and only
“high confidence” peptides were retained corresponding to a
1% false positive rate at peptide level. Data for the affinity-
chromatography and label-free quantitative proteomics were
deposited and are available in PRIDE at the following links:
identification of the S. cerevisiae ZMP binders (project acces-
sion number PXD007780) and effect of acadesine and overex-
pression of the karyopherin Kap123 on nuclear abundance of
yeast proteins (project accession number PXD007779).
His6–Ura6 protein expression and purification
The His6–Ura6 protein was expressed in BL21 C41(DE3)-
pLysS bacteria (33) by transformation of the URA6-HIS6
plasmid (p5334). Transformants were grown overnight in LB
medium	 ampicillin, diluted in 500ml of the samemedium to
A600 nm  0.005 and grown for 4 h at 30 °C before isopropyl
-D-1-thiogalactopyranoside addition (2 mM). The cells were
harvested by centrifugation (5,000 g for 10 min at 4 °C) after
2 h 30 min at 30 °C, and the cell pellet was washed with 50 mM
Tris-HCl, pH7, 0.15MKCl and frozen at80 °C. The pellet was
resuspended in 50 mM Tris-HCl, pH 7, 0.1 M KCl, 1 mM EDTA,
1 mM DTT containing a tablet of protease/phosphatase inhibi-
tor (buffer B). The cells were disrupted by four cycles of 1 min
sonication on ice, and the suspension was clarified by centrifu-
gation (21,000  g) for 30 min at 4 °C. The supernatant was
dialyzed twice against buffer B without EDTA (buffer C) con-
taining 10mM imidazole and then loaded onto 1.5ml of nickel–
nitrilotriacetic acid resin (Qiagen). The resin was washed with
15 volumes of Buffer C containing 50 mM imidazole, and puri-
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fied His6–Ura6 protein was then eluted with 250mM imidazole
in buffer C. The purified His6–Ura6 protein was concentrated
(0.7 ml at 10 mg/ml), aliquoted and frozen at80 °C.
Ura6 enzymatic activity
Ura6 enzymatic activity was measured on both total protein
extracts from bacteria (containing the His6–Ura6 expressing
plasmid (p5334) or the empty vector (pET15b; catalog no.
69661-3; Merck–Novagen)) and on the purified protein. In
each case, measurements were carried out using initial rate
conditions that were stable for at least 30 min at 30 °C. Enzy-
matic measurements were performed in 100 mM Tris-HCl, pH
7.5 buffer containing 100mMKCl, 5mMMgCl2, 2mMATP, and
1mMZMP. The reactions were started by addition of either the
purified protein (at 1 g/ml in enzymatic assay) or the total
protein extracts from bacteria expressing or not His6–Ura6
(each at final concentration of 100 g/ml in enzymatic assays).
All enzymatic reactionswere stoppedby boiling (3min at 80 °C)
a 100-l aliquot of the reactionmix in 900l of ethanol, 10 mM
HEPES, pH 7 (4/1 v/v). Quantification of the reaction prod-
uct(s) was done by LC under conditions described for in-
tracellular metabolites determination. ZDP and ZTP standard
solutions used for quantification were purchased from Jena
Biosciences (catalog nos. NU-1167 andNU-1166, respectively).
Quantification and statistical analysis
All tests for significance were according toWelch’s unpaired
t tests, assuming bilateral distribution and unequal variances,
by comparison with the relevant control as specified in legends
of the figures and supplemental figures Experiments were in
each case performed on at least three biologically independent
samples (n 3), as detailed in each figure legend. Significance
was defined by p values and indicated as *, p 0.05; **, p 0.01;
***, p 0.001; ****, p 0.0001; NS, nonsignificant (p
 0.05).
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Figure S1. The mutation rate is not affected by AICAR feeding in yeast. 
Quadruple mutant cells (ade16 ade17 ade8 his1, Y6986) were transformed (B) or not (A) with the 
plasmid allowing URA6 overexpression (p4919). In each condition, twelve independent cell cultures 
were inoculated at low cell density (100 cells/ml) in a non-selective medium (SD casaWA) containing 
or not (none) AICAR (1 mM) and were grown for 72 h at 30°C to reach a cell density of about 8.107 
cells/ml. Dilutions of each culture were plated on SD medium supplemented with uracil, adenine, 
histidine and containing or not canavanin (0.35 mM), a toxic analog of arginine. The mutation rate was 
determined from the number of canavanin-resistant clones by the method described by Hall et al 
(Hall,B.M., Ma, C.X., Liang, P., and Singh, K.K. (2009). Fluctuation AnaLysis CalculatOR: a Web 
tool for the determination of mutation rate using Luria–Delbrück fluctuation analysis. Bioinformatics 
5, 1564–1565). Black and colored bars respectively correspond to the median and the interquartile 
range.  
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Figure S2. The mitotic recombination rate is not significantly modified by AICAR-feeding in 
yeast.  
The pRS316-TINV plasmid carrying two inverted and partial LEU2 sequences was used to estimate 
the effect of AICAR feeding on mitotic recombination rate of an ade16 ade17 ade8 his1 strain 
(Y8480), as described (González-Barrera S, García-Rubio M and  Aguilera A. Genetics. (2002) 
162(2):603-14). Mitotic recombination rate were measured on twelve independent cultures for each 
condition and statistical analysis was performed using a Mann-Whitney test. NS: non-significant 
p>0.05. Bars correspond to the median and the interquartile range.  
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Figure S3. Yeast telomere length is not altered by ZMP accumulation.  
Telomere length was estimated by Southern blotting after XhoI digestion of genomic DNA extracted 
from yeast cells accumulating ZMP by two different means, either endogenously from the purine 
pathway (ade16 ade17; Y1162) or exogenously by AICAR feeding (+; 1 mM) of the ade8 ade16 
ade17 his1 strain (Y2950). The radiolabeled telomeric probe was obtained by PCR on genomic DNA 
with oligonucleotides 5’CAGTTTAGCAGGCATCATCG3’ and 5’ -CGAGAACTTCAA-
CGTTTGCC-3’. Mutants already shown to have a reduced (tel1) or an increased (rif1) telomere length 
were used as controls. 
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Figure S4. ZTP production is not affected in a strain lacking the NDP-kinase gene YNK1. 
ZTP intracellular relative content was determined by High Performance Ion Chromatography on ade16 
ade17 AICAR-accumulating cells either ynk1 (Y9715; orange and red dots) or YNK1 (Y1162; light 
and dark green dots). Cells were transformed with a plasmid allowing URA6 overexpression (p4919) 
or with the control empty vector. Metabolite extractions were done on transformants exponentially 
grown for 24 h in SDcasaWA medium. Analyses were done on three independent metabolite 
extractions and standard deviation is presented. Statistics correspond to a Welch’s t-test: NS: Non-
significant p>0.05. Black lines correspond to the mean. Relative ZTP content was set at 1 for the 
content measured in the ade16 ade17 YNK1 strain containing the empty vector (light green dots). 
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Figure S5. Biological Process GO-term enrichment analyses for the AMP- (A), SZMP- (B) and 
AICAR-binders (C) identified by affinity chromatography.  The complete list of proteins identified 
in each case is presented in Table S1 part B-D. GO-term analyses were performed using the Gene 
Ontology Consortium web site (http://www.geneontology.org/). 
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Figure S6. AICAR sensitivity is not altered by deletion of SNF4, the yeast gene for AMPK 
gamma subunit. 
Yeast cells (Y8480 (SNF4) and Y10867 (snf4)) were serially diluted and spotted on SDcasaWA 
medium containing, or lacking, AICAR. Plates were imaged after 2 days at 30°C. 
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Figure S7. Effect of ZMP-binder gene overexpression on AICAR sensitivity. 
Cells (ade16 ade17 ade8 his1 (Y2950; A-B) or ade3 ade16 ade17 ade8 his1 (Y8908; C)) were 
transformed with plasmids allowing overexpression of selected ZMP binder genes (boxed in yellow in 
Fig. 4) or by the cognate empty vector (None). Transformants were serially diluted and spotted on SC-
Leu (A-B) or SDcasaWA medium (C-G) containing or not AICAR. Plates were imaged after 2 days at 
30°C (A-B) or 37°C (C-G). 
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Figure S8. Nuclear localization of NLS-RFPL25-GFP is not affected by AICAR. 
A-B, AICAR accumulation does not influence Rpl25 localization. A, NLS-Rpl25 mainly localizes in 
the nucleus, irrespective of AICAR accumulation. Cells (ade8 ade16 ade17 his1; Y8480) expressing 
NLS-Rpl25-GFP were incubated 2 h ± 2 mM AICAR at 30°C and imaged. B, NLS-Rpl25 mainly 
localizes in the cytoplasm in kap123 deleted cells, irrespective of AICAR accumulation. Cells (kap123 
ade8 ade16 ade17 his1; Y9623) expressing NLS-Rpl25-GFP were incubated 2 h ± 2 mM AICAR at 
30°C and imaged. In A-B, a threshold 25% higher than the mean fluorescence field was applied to 
determine Rpl25 localization (N=3). Representative pictures are shown. White dashed lines: cells. Bar 
size is 2 μm. C, AICAR accumulation does not influence Rpl25 nuclear fluorescence intensity. 
Analysis was carried out on cells as described in (A). Using ImageJ software, 11 slides of a Z-stack 
were summed and projected. Fluorescence background (i.e field without cells) was measured and 
subtracted from the pictures. Then, circles containing Rpl25-GFP signal were drawn around the 
nucleus (Int), and the nuclear fluorescence intensity was calculated as follows: nf = (Int/ circle area). 
Importantly, nucleus areas do not change with or without AICAR. P-value was determined with a 
Welch’s t-Test and mean and SD are indicated (red lines). Cells were observed in a fully automated 
Zeiss 200M inverted microscope (Carl Zeiss, Thornwood, NY) equipped with a MS-2000 stage 
(Applied Scientific Instrumentation, Eugene, OR), a Lambda LS 175 Watt xenon light source (Sutter, 
Novato, CA), a 100X 1.4NA Plan-Apochromat objective, and a 5 position filter turret. For GFP 
imaging, we used a FITC filter (Excitation: HQ487/25 – Emission: HQ535/40 – BS: Q505lp). 
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Figure S9. AICAR sensitivity of bre1, swd1 and swd3 mutants is suppressed by KAP123 
overexpression. Yeast cells (ade8 ade16 ade17 his1 (Y2950), ade8 ade16 ade17 his1 set1 (Y9168), 
ade8 ade16 ade17 his1 bre1 (Y9082), ade8 ade16 ade17 his1 swd1 (Y9479) and ade8 ade16 ade17 
his1 swd3 (Y9480)) were transformed by the plasmid allowing overexpression of KAP123 (p4983) or 
by the cognate empty vector (YepLac195; None). Transformants were serially diluted and spotted on 
SDcasaWA medium containing, or lacking, AICAR. Plates were imaged after 2 days at 37°C. 
Table S1 part A: List of the 74 proteins bound to  ZMP-affinity resin at least four times on 6 independent experiments
Fold found on 
ORF Protein ZMP-resin Protein function
name name (6 columns)
YCR088W Abp1 6 Actin-binding protein of the cortical actin cytoskeleton, important for activation of the Arp2/3 complex that plays a key role actin in cytoskeleton organization
YOR335C Ala1 6 Cytoplasmic and mitochondrial alanyl-tRNA synthetase, required for protein synthesis; point mutation (cdc64-1 allele) causes cell cycle arrest at G1; lethality of null mutation is functionally complemented by human homolog
YOR133W Eft1 6 Elongation factor 2 (EF-2), also encoded by EFT2; catalyzes ribosomal translocation during protein synthesis; contains diphthamide, the unique posttranslationally modified histidine residue specifically ADP-ribosylated by diphtheria toxin
YEL046C Gly1 6 Threonine aldolase, catalyzes the cleavage of L-allo-threonine and L-threonine to glycine; involved in glycine biosynthesis
YMR186W Hsc82 6 Cytoplasmic chaperone of the Hsp90 family, redundant in function and nearly identical with Hsp82p, and together they are essential; expressed constitutively at 10-fold higher basal levels than HSP82 and induced 2-3 fold by heat shock
YGR240C Pfk1 6 Alpha subunit of heterooctameric phosphofructokinase involved in glycolysis, indispensable for anaerobic growth, activated by fructose-2,6-bisphosphate and AMP, mutation inhibits glucose induction of cell cycle-related genes
YMR205C Pfk2 6 Beta subunit of heterooctameric phosphofructokinase involved in glycolysis, indispensable for anaerobic growth, activated by fructose-2,6-bisphosphate and AMP, mutation inhibits glucose induction of cell cycle-related genes
YGL037C Pnc1 6 Nicotinamidase that converts nicotinamide to nicotinic acid as part of the NAD(+) salvage pathway, required for life span extension by calorie restriction; PNC1 expression responds to all known stimuli that extend replicative life span
YDR023W Ses1 6 Cytosolic seryl-tRNA synthetase, class II aminoacyl-tRNA synthetase that aminoacylates tRNA(Ser), displays tRNA-dependent amino acid recognition which enhances discrimination of the serine substrate, interacts with peroxin Pex21p
YAL005C Ssa1 6 ATPase involved in protein folding and nuclear localization signal (NLS)-directed nuclear transport; member of heat shock protein 70 (HSP70) family; forms a chaperone complex with Ydj1p; localized to the nucleus, cytoplasm, and cell wall
YLL024C Ssa2 6 ATP binding protein involved in protein folding and vacuolar import of proteins; member of heat shock protein 70 (HSP70) family; associated with the chaperonin-containing T-complex; present in the cytoplasm, vacuolar membrane and cell wall
YPL106C Sse1 6 ATPase that is a component of the heat shock protein Hsp90 chaperone complex; binds unfolded proteins; member of the heat shock protein 70 (HSP70) family; localized to the cytoplasm
YOR027W Sti1 6 Hsp90 cochaperone, interacts with the Ssa group of the cytosolic Hsp70 chaperones; activates the ATPase activity of Ssa1p; homolog of mammalian Hop protein
YPR080W Tef1 6 Translational elongation factor EF-1 alpha; also encoded by TEF2; functions in the binding reaction of aminoacyl-tRNA (AA-tRNA) to ribosomes; may also have a role in tRNA re-export from the nucleus
YKL056C Tma19 6 Protein that associates with ribosomes; homolog of translationally controlled tumor protein; green fluorescent protein (GFP)-fusion protein localizes to the cytoplasm and relocates to the mitochondrial outer surface upon oxidative stress
YML028W Tsa1 6 Thioredoxin peroxidase, acts as both a ribosome-associated and free cytoplasmic antioxidant; self-associates to form a high-molecular weight chaperone complex under oxidative stress; deletion results in mutator phenotype
YKL210W Uba1 6 Ubiquitin activating enzyme (E1), involved in ubiquitin-mediated protein degradation and essential for viability
YBR127C Vma2 6 Subunit B of the eight-subunit V1 peripheral membrane domain of the vacuolar H+-ATPase (V-ATPase), an electrogenic proton pump found throughout the endomembrane system; contains nucleotide binding sites; also detected in the cytoplasm
YFL039C Act1 5 Actin, structural protein involved in cell polarization, endocytosis, and other cytoskeletal functions
YLR359W Ade13 5 Adenylosuccinate lyase, catalyzes two steps in the 'de novo' purine nucleotide biosynthetic pathway; expression is repressed by adenine and activated by Bas1p and Pho2p; mutations in human ortholog ADSL cause adenylosuccinase deficiency
YOL086C Adh1 5 Alcohol dehydrogenase, fermentative isozyme active as homo- or heterotetramers; required for the reduction of acetaldehyde to ethanol, the last step in the glycolytic pathway
YPL061W Ald6 5 Cytosolic aldehyde dehydrogenase, activated by Mg2+ and utilizes NADP+ as the preferred coenzyme; required for conversion of acetaldehyde to acetate; constitutively expressed; locates to the mitochondrial outer surface upon oxidative stress
YPR145W Asn1 5 Asparagine synthetase, isozyme of Asn2p; catalyzes the synthesis of L-asparagine from L-aspartate in the asparagine biosynthetic pathway
YGR124W Asn2 5 Asparagine synthetase, isozyme of Asn1p; catalyzes the synthesis of L-asparagine from L-aspartate in the asparagine biosynthetic pathway
YDR321W Asp1 5 Cytosolic L-asparaginase, involved in asparagine catabolism
YER177W Bmh1 5 14-3-3 protein, major isoform; controls proteome at post-transcriptional level, binds proteins and DNA, involved in regulation of many processes including exocytosis, vesicle transport, Ras/MAPK signaling, and rapamycin-sensitive signaling
YHR068W Dys1 5 Deoxyhypusine synthase, catalyzes formation of deoxyhypusine, the first step in hypusine biosynthesis; triggers posttranslational hypusination of translation elongation factor eIF-5A and regulates its intracellular levels; tetrameric
YMR208W Erg12 5 Mevalonate kinase, acts in the biosynthesis of isoprenoids and sterols, including ergosterol, from mevalonate
YKL060C Fba1 5 Fructose 1,6-bisphosphate aldolase; required for glycolysis and gluconeogenesis; catalyzes conversion of fructose 1,6 bisphosphate to glyceraldehyde-3-P and dihydroxyacetone-P
YOR375C Gdh1 5 NADP(+)-dependent glutamate dehydrogenase, synthesizes glutamate from ammonia and alpha-ketoglutarate; rate of alpha-ketoglutarate utilization differs from Gdh3p; expression regulated by nitrogen and carbon sources
YPL240C Hsp82 5 Hsp90 chaperone required for pheromone signaling and negative regulation of Hsf1p; docks with Tom70p for mitochondrial preprotein delivery; promotes telomerase DNA binding and nucleotide addition; interacts with Cns1p, Cpr6p, Cpr7p, Sti1p
YJR070C Lia1 5 Deoxyhypusine hydroxylase, a HEAT-repeat containing metalloenzyme that catalyzes hypusine formation; binds to and is required for the modification of Hyp2p (eIF5A); complements S. pombe mmd1 mutants defective in mitochondrial positioning
YPR118W Mri1 5 5'-methylthioribose-1-phosphate isomerase; catalyzes the isomerization of 5-methylthioribose-1-phosphate to 5-methylthioribulose-1-phosphate in the methionine salvage pathway
YER165W Pab1 5 Poly(A) binding protein, part of the 3'-end RNA-processing complex, mediates interactions between the 5' cap structure and the 3' mRNA poly(A) tail, involved in control of poly(A) tail length, interacts with translation factor eIF-4G
YLR044C Pdc1 5 Major of three pyruvate decarboxylase isozymes, key enzyme in alcoholic fermentation, decarboxylates pyruvate to acetaldehyde; subject to glucose-, ethanol-, and autoregulation; involved in amino acid catabolism
YBR218C Pyc2 5 Pyruvate carboxylase isoform, cytoplasmic enzyme that converts pyruvate to oxaloacetate; highly similar to isoform Pyc1p but differentially regulated; mutations in the human homolog are associated with lactic acidosis
YOR184W Ser1 5 3-phosphoserine aminotransferase, catalyzes the formation of phosphoserine from 3-phosphohydroxypyruvate, required for serine and glycine biosynthesis; regulated by the general control of amino acid biosynthesis mediated by Gcn4p
YJR045C Ssc1 5 Hsp70 family ATPase, constituent of the import motor component of the Translocase of the Inner Mitochondrial membrane (TIM23 complex); involved in protein translocation and folding; subunit of SceI endonuclease
YNL244C Sui1 5 Translation initiation factor eIF1; component of a complex involved in recognition of the initiator codon; modulates translation accuracy at the initiation phase
YKR059W Tif1 5 Translation initiation factor eIF4A, identical to Tif2p; DEA(D/H)-box RNA helicase that couples ATPase activity to RNA binding and unwinding; forms a dumbbell structure of two compact domains connected by a linker; interacts with eIF4G
YPR163C Tif3 5 Translation initiation factor eIF-4B, has RNA annealing activity; contains an RNA recognition motif and binds to single-stranded RNA
YBR126C Tps1 5 Synthase subunit of trehalose-6-phosphate synthase/phosphatase complex, which synthesizes the storage carbohydrate trehalose; also found in a monomeric form; expression is induced by the stress response and repressed by the Ras-cAMP pathway
YOR187W Tuf1 5 Mitochondrial translation elongation factor Tu; comprises both GTPase and guanine nucleotide exchange factor activities, while these activities are found in separate proteins in S. pombe and humans
YGR094W Vas1 5 Mitochondrial and cytoplasmic valyl-tRNA synthetase
YMR300C Ade4 4 Phosphoribosylpyrophosphate amidotransferase (PRPPAT; amidophosphoribosyltransferase), catalyzes first step of the 'de novo' purine nucleotide biosynthetic pathway
YJR065C Arp3 4 Essential component of the Arp2/3 complex; Arp2/3 is a highly conserved actin nucleation center required for the motility and integrity of actin patches; involved in endocytosis and membrane growth and polarity 
YGR282C Bgl2 4 Endo-beta-1,3-glucanase; major protein of the cell wall, involved in cell wall maintenance; involved in incorporation of newly synthesized mannoprotein molecules into the cell wall
YDR099W Bmh2 4 14-3-3 protein, minor isoform; controls proteome at post-transcriptional level, binds proteins and DNA, involved in regulation of many processes including exocytosis, vesicle transport, Ras/MAPK signaling, and rapamycin-sensitive signaling
YAL038W Cdc19 4 Pyruvate kinase, functions as a homotetramer in glycolysis to convert phosphoenolpyruvate to pyruvate, the input for aerobic (TCA cycle) or anaerobic (glucose fermentation) respiration
YJR109C Cpa2 4 Large subunit of carbamoyl phosphate synthetase, which catalyzes a step in the synthesis of citrulline, an arginine precursor
YAL003W Efb1 4 Translation elongation factor 1 beta; stimulates nucleotide exchange to regenerate EF-1 alpha-GTP for the next elongation cycle; part of the EF-1 complex, which facilitates binding of aminoacyl-tRNA to the ribosomal A site
YHR174W Eno2 4 Enolase II, a phosphopyruvate hydratase that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate during glycolysis and the reverse reaction during gluconeogenesis; expression is induced in response to glucose
YDR518W Eug1 4 Protein disulfide isomerase of the endoplasmic reticulum lumen; EUG1 has a paralog, PDI1, that arose from the whole genome duplication; function overlaps with that of Pdi1p; may interact with nascent polypeptides in the ER
YBR101C Fes1 4 Hsp70 (Ssa1p) nucleotide exchange factor, cytosolic homolog of Sil1p, which is the nucleotide exchange factor for BiP (Kar2p) in the endoplasmic reticulum
YLR060W Frs1 4 Beta subunit of cytoplasmic phenylalanyl-tRNA synthetase; forms a tetramer with Frs2p to generate active enzyme; able to hydrolyze mis-aminoacylated tRNA-Phe, which could contribute to translational quality control
YER133W Glc7 4 Type 1 serine/threonine protein phosphatase catalytic subunit, involved in many processes (eg: glycogen metabolism, sporulation, mitosis); accumulates at mating projections by interaction with Afr1p; interacts with many regulatory subunits
YLL026W Hsp104 4 Disaggregase; heat shock protein that cooperates with Ydj1p (Hsp40) and Ssa1p (Hsp70) to refold and reactivate previously denatured, aggregated proteins; responsive to stresses including: heat, ethanol, and sodium arsenite
YEL034W Hyp2 4 Translation elongation factor eIF-5A, previously thought to function in translation initiation; similar to and functionally redundant with Anb1p; structural homolog of bacterial EF-P; undergoes an essential hypusination modification
YPL117C Idi1 4 Isopentenyl diphosphate:dimethylallyl diphosphate isomerase (IPP isomerase), catalyzes an essential activation step in the isoprenoid biosynthetic pathway; required for viability
YER110C Kap123 4 Karyopherin beta, mediates nuclear import of ribosomal proteins prior to assembly into ribosomes and import of histones H3 and H4; localizes to the nuclear pore, nucleus, and cytoplasm; exhibits genetic interactions with RAI1
YOR232W Mge1 4 Mitochondrial matrix cochaperone, acts as a nucleotide release factor for Ssc1p in protein translocation and folding; also acts as cochaperone for Ssq1p in folding of Fe-S cluster proteins; homolog of E. coli GrpE
YJL026W Rnr2 4 Ribonucleotide-diphosphate reductase (RNR), small subunit; the RNR complex catalyzes the rate-limiting step in dNTP synthesis and is regulated by DNA replication and DNA damage checkpoint pathways via localization of the small subunits
YGR180C Rnr4 4 Ribonucleotide-diphosphate reductase (RNR) small subunit; the RNR complex catalyzes the rate-limiting step in dNTP synthesis and is regulated by DNA replication and DNA damage checkpoint pathways via localization of the small subunits
YOL039W Rpp2a 4 Ribosomal protein P2 alpha, a component of the ribosomal stalk, which is involved in the interaction between translational elongation factors and the ribosome; regulates the accumulation of P1 (Rpp1Ap and Rpp1Bp) in the cytoplasm
YDR382W Rpp2b 4 Ribosomal protein P2 beta, a component of the ribosomal stalk, which is involved in the interaction between translational elongation factors and the ribosome; regulates the accumulation of P1 (Rpp1Ap and Rpp1Bp) in the cytoplasm
YGR214W Rps0a 4 Protein component of the small (40S) ribosomal subunit, nearly identical to Rps0Bp; required for maturation of 18S rRNA along with Rps0Bp; deletion of either RPS0 gene reduces growth rate, deletion of both genes is lethal
YKR057W Rps21a 4 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps21Bp and has similarity to rat S21 ribosomal protein
YBL058W Shp1 4 UBX domain-containing substrate adaptor for Cdc48p; ubiquitin regulatory X domain-containing protein that acts as a substrate recruiting cofactor for Cdc48p; positively regulates Glc7p PPase activity
YNL138W Srv2 4 CAP (cyclase-associated protein); N-terminus binds adenylate cyclase and facilitates activation by RAS; N-terminus forms novel hexameric star-shaped shuriken structures that directly catalyze cofilin-mediated severing of actin filaments
YNL209W Ssb2 4 Cytoplasmic ATPase that is a ribosome-associated molecular chaperone, functions with J-protein partner Zuo1p; may be involved in the folding of newly-synthesized polypeptide chains; member of the HSP70 family; homolog of SSB1
YDL084W Sub2 4 Component of the TREX complex required for nuclear mRNA export; member of the DEAD-box RNA helicase superfamily and is involved in early and late steps of spliceosome assembly; homolog of the human splicing factor hUAP56
YDL185W Vma1 4 Subunit A of the eight-subunit V1 peripheral membrane domain of the vacuolar H+-ATPase; protein precursor undergoes self-catalyzed splicing to yield the extein Tfp1p and the intein Vde (PI-SceI), which is a site-specific endonuclease
YBL036C Ybl036c 4 Putative non-specific single-domain racemase; based on structural similarity; binds pyridoxal 5'-phosphate; expression of GFP-fusion protein induced in response to the DNA-damaging agent MMS
YDR002W Yrb1 4 Ran GTPase binding protein; involved in nuclear protein import and RNA export, ubiquitin-mediated protein degradation during the cell cycle; shuttles between the nucleus and cytoplasm; is essential; homolog of human RanBP1
Table S1 part B : List of the 67 proteins bound to  AMP-affinity resin at least twice on 3 independent experiments
Fold found on 
OFR PROTEIN AMP-resin Protein function
name name (3 columns)
YFL039C Act1 3 Actin, structural protein involved in cell polarization, endocytosis, and other cytoskeletal functions
YOL086C Adh1 3 Alcohol dehydrogenase, fermentative isozyme active as homo- or heterotetramers; required for the reduction of acetaldehyde to ethanol, the last step in the glycolytic pathway
YJR105W Ado1 3 Adenosine kinase, required for the utilization of S-adenosylmethionine (AdoMet); may be involved in recycling adenosine produced through the methyl cycle
YML022W Apt1 3 Adenine phosphoribosyltransferase, catalyzes the formation of AMP from adenine and 5-phosphoribosylpyrophosphate; involved in the salvage pathway of purine nucleotide biosynthesis
YAL038W Cdc19 3 Pyruvate kinase, functions as a homotetramer in glycolysis to convert phosphoenolpyruvate to pyruvate, the input for aerobic (TCA cycle) or anaerobic (glucose fermentation) respiration
YAL003W Efb1 3 Translation elongation factor 1 beta; stimulates nucleotide exchange to regenerate EF-1 alpha-GTP for the next elongation cycle; part of the EF-1 complex, which facilitates binding of aminoacyl-tRNA to the ribosomal A site
YOR133W Eft1 3 Elongation factor 2 (EF-2), also encoded by EFT2; catalyzes ribosomal translocation during protein synthesis; contains diphthamide, the unique posttranslationally modified histidine residue specifically ADP-ribosylated by diphtheria toxin
YHR174W Eno2 3 Enolase II, a phosphopyruvate hydratase that catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate during glycolysis and the reverse reaction during gluconeogenesis; expression is induced in response to glucose
YPR035W Gln1 3 Glutamine synthetase (GS), synthesizes glutamine from glutamate and ammonia; with Glt1p, forms the secondary pathway for glutamate biosynthesis from ammonia; expression regulated by nitrogen source and by amino acid limitation
YDL125C Hnt1 3 Adenosine 5'-monophosphoramidase; interacts physically and genetically with Kin28p, a CDK and TFIIK subunit, and genetically with CAK1; member of the histidine triad (HIT) superfamily of nucleotide-binding proteins and similar to Hint
YMR186W Hsc82 3 Cytoplasmic chaperone of the Hsp90 family, redundant in function and nearly identical with Hsp82p, and together they are essential; expressed constitutively at 10-fold higher basal levels than HSP82 and induced 2-3 fold by heat shock
YLR259C Hsp60 3 Tetradecameric mitochondrial chaperonin required for ATP-dependent folding of precursor polypeptides and complex assembly; prevents aggregation and mediates protein refolding after heat shock; role in mtDNA transmission; phosphorylated
YLR432W Imd3 3 Inosine monophosphate dehydrogenase, catalyzes the first step of GMP biosynthesis, member of a four-gene family in S. cerevisiae, constitutively expressed
YJL034W Kar2 3 ATPase involved in protein import into the ER, also acts as a chaperone to mediate protein folding in the ER and may play a role in ER export of soluble proteins; regulates the unfolded protein response via interaction with Ire1p
YLR044C Pdc1 3 Major of three pyruvate decarboxylase isozymes, key enzyme in alcoholic fermentation, decarboxylates pyruvate to acetaldehyde; subject to glucose-, ethanol-, and autoregulation; involved in amino acid catabolism
YCR012W Pgk1 3 3-phosphoglycerate kinase, catalyzes transfer of high-energy phosphoryl groups from the acyl phosphate of 1,3-bisphosphoglycerate to ADP to produce ATP; key enzyme in glycolysis and gluconeogenesis
YHR037W Put2 3 Delta-1-pyrroline-5-carboxylate dehydrogenase, nuclear-encoded mitochondrial protein involved in utilization of proline as sole nitrogen source; deficiency of the human homolog causes HPII, an autosomal recessive inborn error of metabolism
YMR142C Rpl13b 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl13Ap; not essential for viability; has similarity to rat L13 ribosomal protein
YBR031W Rpl4a 3 N-terminally acetylated protein component of the large (60S) ribosomal subunit, nearly identical to Rpl4Bp and has similarity to E. coli L4 and rat L4 ribosomal proteins
YER043C Sah1 3 S-adenosyl-L-homocysteine hydrolase, catabolizes S-adenosyl-L-homocysteine which is formed after donation of the activated methyl group of S-adenosyl-L-methionine (AdoMet) to an acceptor
YAL005C Ssa1 3 ATPase involved in protein folding and nuclear localization signal (NLS)-directed nuclear transport; member of heat shock protein 70 (HSP70) family; forms a chaperone complex with Ydj1p; 
YLL024C Ssa2 3 ATP binding protein involved in protein folding and vacuolar import of proteins; member of heat shock protein 70 (HSP70) family; associated with the chaperonin-containing T-complex
YDL229W Ssb1 3 Cytoplasmic ATPase that is a ribosome-associated molecular chaperone, functions with J-protein partner Zuo1p; may be involved in folding of newly-made polypeptide chains; member of the HSP70 family; interacts with phosphatase subunit Reg1
YNL209W Ssb2 3 Cytoplasmic ATPase that is a ribosome-associated molecular chaperone, functions with J-protein partner Zuo1p; may be involved in the folding of newly-synthesized polypeptide chains; member of the HSP70 family; homolog of SSB1
YJR045C Ssc1 3 Hsp70 family ATPase, constituent of the import motor component of the Translocase of the Inner Mitochondrial membrane (TIM23 complex); involved in protein translocation and folding; subunit of SceI endonuclease
YJL052W Tdh1 3 Glyceraldehyde-3-phosphate dehydrogenase, isozyme 1, involved in glycolysis and gluconeogenesis; tetramer that catalyzes the reaction of glyceraldehyde-3-phosphate to 1,3 bis-phosphoglycerate; detected in the cytoplasm and cell wall
YJR009C Tdh2 3 Glyceraldehyde-3-phosphate dehydrogenase, isozyme 2, involved in glycolysis and gluconeogenesis; tetramer that catalyzes the reaction of glyceraldehyde-3-phosphate to 1,3 bis-phosphoglycerate; detected in the cytoplasm and cell wall
YGR192C Tdh3 3 Glyceraldehyde-3-phosphate dehydrogenase, isozyme 3, involved in glycolysis and gluconeogenesis; tetramer that catalyzes the reaction of glyceraldehyde-3-phosphate to 1,3 bis-phosphoglycerate; detected in the cytoplasm and cell wall
YPR080W Tef1 3 Translational elongation factor EF-1 alpha; also encoded by TEF2; functions in the binding reaction of aminoacyl-tRNA (AA-tRNA) to ribosomes; may also have a role in tRNA re-export from the nucleus
YKL067W Ynk1 3 Nucleoside diphosphate kinase, catalyzes the transfer of gamma phosphates from nucleoside triphosphates, usually ATP, to nucleoside diphosphates by a mechanism that involves formation of an autophosphorylated enzyme intermediate
YLR153C Acs2 2 Acetyl-coA synthetase isoform which, along with Acs1p, is the nuclear source of acetyl-coA for histone acetylation; mutants affect global transcription; required for growth on glucose; expressed under anaerobic conditions
YLR028C Ade16 2 Enzyme of 'de novo' purine biosynthesis containing both 5-aminoimidazole-4-carboxamide ribonucleotide transformylase and inosine monophosphate cyclohydrolase activities, isozyme of Ade17p; ade16 ade17 mutants require adenine and histidine
YLR109W Ahp1 2 Thiol-specific peroxiredoxin, reduces hydroperoxides to protect against oxidative damage; function in vivo requires covalent conjugation to Urm1p
YMR116C Asc1 2 G-protein beta subunit and guanine nucleotide dissociation inhibitor for Gpa2p; ortholog of RACK1 that inhibits translation; core component of the small (40S) ribosomal subunit; represses Gcn4p in the absence of amino acid starvation
YFL028C Caf16 2 Part of evolutionarily-conserved CCR4-NOT regulatory complex; contains single ABC-type ATPase domain but no transmembrane domain; interacts with several subunits of Mediator
YMR173W Ddr48 2 DNA damage-responsive protein, expression is increased in response to heat-shock stress or treatments that produce DNA lesions; contains multiple repeats of the amino acid sequence NNNDSYGS
YKL054C Def1 2 RNAPII degradation factor, forms a complex with Rad26p in chromatin, enables ubiquitination and proteolysis of RNAPII present in an elongation complex; mutant is deficient in Zip1p loading onto chromosomes during meiosis
YMR124W Epo1 2 Protein involved in septin-ER tethering; interacts with ER membrane protein, Scs2p, and Shs1p, a septin ring component, at bud neck to create ER diffusion barrier
YMR029C Far8 2 Protein involved in recovery from cell cycle arrest in response to pheromone, in a Far1p-independent pathway; interacts with Far3p, Far7p, Far9p, Far10p, and Far11p
YNL068C Fkh2 2 Forkhead family transcription factor with a major role in the expression of G2/M phase genes; positively regulates transcriptional elongation; negative role in chromatin silencing at HML and HMR; substrate of the Cdc28p/Clb5p kinase
YDR236C Fmn1 2 Riboflavin kinase, phosphorylates riboflavin to form riboflavin monophosphate (FMN), which is a necessary cofactor for many enzymes; localizes to microsomes and to the mitochondrial inner membrane
YHR176W Fmo1 2 Flavin-containing monooxygenase, localized to the cytoplasmic face of the ER membrane; catalyzes oxidation of biological thiols to maintain the ER redox buffer ratio for correct folding of disulfide-bonded proteins
YKL152C Gpm1 2 Tetrameric phosphoglycerate mutase, mediates the conversion of 3-phosphoglycerate to 2-phosphoglycerate during glycolysis and the reverse reaction during gluconeogenesis
YOR020C Hsp10 2 Mitochondrial matrix co-chaperonin that inhibits the ATPase activity of Hsp60p, a mitochondrial chaperonin; involved in protein folding and sorting in the mitochondria; 10 kD heat shock protein with similarity to E. coli groES
YLR355C Ilv5 2 Bifunctional acetohydroxyacid reductoisomerase and mtDNA binding protein; involved in branched-chain amino acid biosynthesis and maintenance of wild-type mitochondrial DNA; found in mitochondrial nucleoids
YML056C Imd4 2 Inosine monophosphate dehydrogenase, catalyzes the first step of GMP biosynthesis, member of a four-gene family in S. cerevisiae, constitutively expressed
YOR197W Mca1 2 Putative cysteine protease similar to mammalian caspases; involved in regulation of apoptosis upon H2O2 treatment; contributes to clearance of insoluble protein aggregates during normal growth; may be involved in cell cycle progression
YLR203C Mss51 2 Specific translational activator for the mitochondrial COX1 mRNA; loosely associated with the matrix face of the mitochondrial inner membrane; influences both COX1 mRNA translation and Cox1p assembly into cytochrome c oxidase
YKR080W Mtd1 2 NAD-dependent 5,10-methylenetetrahydrafolate dehydrogenase, plays a catalytic role in oxidation of cytoplasmic one-carbon units; expression is regulated by Bas1p and Bas2p, repressed by adenine, and may be induced by inositol and choline
YDR432W Npl3 2 RNA-binding protein that promotes elongation, regulates termination, and carries poly(A) mRNA from nucleus to cytoplasm; required for pre-mRNA splicing; dissociation from mRNAs promoted by Mtr10p; phosphorylated by Sky1p in the cytoplasm
YJL041W Nsp1 2 Essential component of the nuclear pore complex, which mediates nuclear import and export, found in both the Nup82 and Nic96 complexes
YLR335W Nup2 2 Nucleoporin involved in nucleocytoplasmic transport, binds to either the nucleoplasmic or cytoplasmic faces of the nuclear pore complex depending on Ran-GTP levels; also has a role in chromatin organization
YIR006C Pan1 2 Part of actin cytoskeleton-regulatory complex Pan1p-Sla1p-End3p, associates with actin patches on the cell cortex; promotes protein-protein interactions essential for endocytosis; previously thought to be a subunit of poly(A) ribonuclease
YDL055C Psa1 2 GDP-mannose pyrophosphorylase (mannose-1-phosphate guanyltransferase), synthesizes GDP-mannose from GTP and mannose-1-phosphate in cell wall biosynthesis; required for normal cell wall structure
YEL054C Rpl12a 2 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl12Bp; rpl12a rpl12b double mutant exhibits slow growth and slow translation; has similarity to E. coli L11 and rat L12 ribosomal proteins
YBR084C-A Rpl19a 2 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl19Bp and has similarity to rat L19 ribosomal protein; rpl19a and rpl19b single null mutations result in slow growth, while the double null mutation is lethal
YLR344W Rpl26a 2 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl26Bp and has similarity to E. coli L24 and rat L26 ribosomal proteins; binds to 5.8S rRNA
YBL092W Rpl32 2 Protein component of the large (60S) ribosomal subunit, has similarity to rat L32 ribosomal protein; overexpression disrupts telomeric silencing
YGL076C Rpl7a 2 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl7Bp and has similarity to E. coli L30 and rat L7 ribosomal proteins; contains a conserved C-terminal Nucleic acid Binding Domain (NDB2
YGL147C Rpl9a 2 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl9Bp and has similarity to E. coli L6 and rat L9 ribosomal proteins
YCR031C Rps14a 2 Ribosomal protein 59 of the small subunit, required for ribosome assembly and 20S pre-rRNA processing; mutations confer cryptopleurine resistance; nearly identical to Rps14Bp and similar to E. coli S11 and rat S14 ribosomal proteins
YOL121C Rps19a 2 Protein component of the small (40S) ribosomal subunit, required for assembly and maturation of pre-40 S particles; mutations in human RPS19 are associated with Diamond Blackfan anemia; nearly identical to Rps19Bp
YNL178W Rps3 2 Protein component of the small (40S) ribosomal subunit, has apurinic/apyrimidinic (AP) endonuclease activity; essential for viability; has similarity to E. coli S3 and rat S3 ribosomal proteins
YJR123W Rps5 2 Protein component of the small (40S) ribosomal subunit, the least basic of the non-acidic ribosomal proteins; phosphorylated in vivo; essential for viability; has similarity to E. coli S7 and rat S5 ribosomal proteins
YNL096C Rps7b 2 Protein component of the small (40S) ribosomal subunit, nearly identical to Rps7Ap; interacts with Kti11p; deletion causes hypersensitivity to zymocin; has similarity to rat S7 and Xenopus S8 ribosomal proteins
YER081W Ser3 2 3-phosphoglycerate dehydrogenase, catalyzes the first step in serine and glycine biosynthesis; isozyme of Ser33p
YIL074C Ser33 2 3-phosphoglycerate dehydrogenase, catalyzes the first step in serine and glycine biosynthesis; isozyme of Ser3p
Table S1 part B (continued)
Fold found on 
OFR PROTEIN AMP-resin Protein function
name name (3 columns)
YNL167C Sko1 2 Basic leucine zipper transcription factor of the ATF/CREB family; forms a complex with Tup1p and Cyc8p to both activate and repress transcription; cytosolic and nuclear protein involved in osmotic and oxidative stress responses
YBL007C Sla1 2 Cytoskeletal protein binding protein required for assembly of the cortical actin cytoskeleton; interacts with proteins regulating actin dynamics and proteins required for endocytosis; found in the nucleus and cell cortex; has 3 SH3 domains
YBL075C Ssa3 2 ATPase involved in protein folding and the response to stress; plays a role in SRP-dependent cotranslational protein-membrane targeting and translocation; member of the heat shock protein 70 (HSP70) family; localized to the cytoplasm
YER103W Ssa4 2 Heat shock protein that is highly induced upon stress; plays a role in SRP-dependent cotranslational protein-membrane targeting and translocation; member of the HSP70 family; cytoplasmic protein that concentrates in nuclei upon starvation
YPL106C Sse1 2 ATPase that is a component of the heat shock protein Hsp90 chaperone complex; binds unfolded proteins; member of the heat shock protein 70 (HSP70) family; localized to the cytoplasm
YLR369W Ssq1 2 Mitochondrial hsp70-type molecular chaperone, required for assembly of iron/sulfur clusters into proteins at a step after cluster synthesis, and for maturation of Yfh1p, which is a homolog of human frataxin implicated in Friedreich's ataxia
YOR027W Sti1 2 Hsp90 cochaperone, interacts with the Ssa group of the cytosolic Hsp70 chaperones and activates Ssa1p ATPase activity; interacts with Hsp90 chaperones and inhibits their ATPase activity; homolog of mammalian Hop
YLR150W Stm1 2 Protein required for optimal translation under nutrient stress; perturbs association of Yef3p with ribosomes; involved in TOR signaling; binds G4 quadruplex and purine motif triplex nucleic acid; helps maintain telomere structure
YDL084W Sub2 2 Component of the TREX complex required for nuclear mRNA export; member of the DEAD-box RNA helicase superfamily and is involved in early and late steps of spliceosome assembly; homolog of the human splicing factor hUAP56
YKR059W Tif1 2 Translation initiation factor eIF4A, identical to Tif2p; DEA(D/H)-box RNA helicase that couples ATPase activity to RNA binding and unwinding; forms a dumbbell structure of two compact domains connected by a linker; interacts with eIF4G
YPR163C Tif3 2 Translation initiation factor eIF-4B, has RNA annealing activity; contains an RNA recognition motif and binds to single-stranded RNA
YML028W Tsa1 2 Thioredoxin peroxidase, acts as both a ribosome-associated and free cytoplasmic antioxidant; self-associates to form a high-molecular weight chaperone complex under oxidative stress; deletion results in mutator phenotype
YCR084C Tup1 2 General repressor of transcription, forms complex with Cyc8p, involved in the establishment of repressive chromatin structure through interactions with histones H3 and H4, appears to enhance expression of some genes
YDL185W Vma1 2 Subunit A of the eight-subunit V1 peripheral membrane domain of the vacuolar H+-ATPase; protein precursor undergoes self-catalyzed splicing to yield the extein Tfp1p and the intein Vde (PI-SceI), which is a site-specific endonuclease
Table S1 part C : List of proteins bound to  SZMP-affinity resin at least three times on 4 independent experiments
Fold found on 
ORF Protein SZMP-resin Protein function
name name (4 columns)
YOR198C Bfr1 4 Component of mRNP complexes associated with polyribosomes; implicated in secretion and nuclear segregation; multicopy suppressor of BFA (Brefeldin A) sensitivity
YAL038W Cdc19 4 Pyruvate kinase, functions as a homotetramer in glycolysis to convert phosphoenolpyruvate to pyruvate, the input for aerobic (TCA cycle) or anaerobic (glucose fermentation) respiration
YHR019C Ded81 4 Cytosolic asparaginyl-tRNA synthetase, required for protein synthesis, catalyzes the specific attachment of asparagine to its cognate tRNA
YOR133W Eft1 4 Elongation factor 2 (EF-2), also encoded by EFT2; catalyzes ribosomal translocation during protein synthesis; contains diphthamide, the unique posttranslationally modified histidine residue specifically ADP-ribosylated by diphtheria toxin
YDR385W Eft2 4 Elongation factor 2 (EF-2), also encoded by EFT1; catalyzes ribosomal translocation during protein synthesis; contains diphthamide, the unique posttranslationally modified histidine residue specifically ADP-ribosylated by diphtheria toxin
YHR193C Egd2 4 Alpha subunit of the heteromeric nascent polypeptide-associated complex (NAC) involved in protein sorting and translocation, associated with cytoplasmic ribosomes
YER025W Gcd11 4 Gamma subunit of the translation initiation factor eIF2, involved in the identification of the start codon; binds GTP when forming the ternary complex with GTP and tRNAi-Met
YDR091C Rli1 4 Essential iron-sulfur protein required for ribosome biogenesis and translation initiation and termination; facilitates binding of a multifactor complex (MFC) of initiation factors to the small ribosomal subunit; predicted ABC family ATPase
YPR102C Rpl11a 4 Protein of the large 60S ribosomal subunit, nearly identical to Rpl11Bp but expressed at twice the level; involved in ribosomal assembly; depletion causes degradation of 60S proteins and RNA; similar to E. coli L5 and rat L11
YGR085C Rpl11b 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl11Ap; involved in ribosomal assembly; depletion causes degradation of proteins and RNA of the 60S subunit; has similarity to E. coli L5 and rat L11
YMR142C Rpl13b 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl13Ap; not essential for viability; has similarity to rat L13 ribosomal protein
YNL069C Rpl16b 4 N-terminally acetylated protein component of the large (60S) ribosomal subunit, binds to 5.8 S rRNA; has similarity to Rpl16Ap, E. coli L13 and rat L13a ribosomal proteins; transcriptionally regulated by Rap1p
YKL180W Rpl17a 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl17Bp and has similarity to E. coli L22 and rat L17 ribosomal proteins; copurifies with the Dam1 complex (aka DASH complex)
YBR084C-A Rpl19a 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl19Bp and has similarity to rat L19 ribosomal protein; rpl19a and rpl19b single null mutations result in slow growth, while the double null mutation is lethal
YBL027W Rpl19b 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl19Ap and has similarity to rat L19 ribosomal protein; rpl19a and rpl19b single null mutations result in slow growth, while the double null mutation is lethal
YPL220W Rpl1a 4 N-terminally acetylated protein component of the large (60S) ribosomal subunit, nearly identical to Rpl1Bp and has similarity to E. coli L1 and rat L10a ribosomal proteins; rpl1a rpl1b double null mutation is lethal
YGL135W Rpl1b 4 N-terminally acetylated protein component of the large (60S) ribosomal subunit, nearly identical to Rpl1Ap and has similarity to E. coli L1 and rat L10a ribosomal proteins; rpl1a rpl1b double null mutation is lethal
YMR242C Rpl20a 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl20Bp and has similarity to rat L18a ribosomal protein
YOR312C Rpl20b 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl20Ap and has similarity to rat L18a ribosomal protein
YGR034W Rpl26b 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl26Ap and has similarity to E. coli L24 and rat L26 ribosomal proteins; binds to 5.8S rRNA
YHR010W Rpl27a 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl27Bp and has similarity to rat L27 ribosomal protein
YDR471W Rpl27b 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl27Ap and has similarity to rat L27 ribosomal protein
YOR063W Rpl3 4 Protein component of the large (60S) ribosomal subunit, has similarity to E. coli L3 and rat L3 ribosomal proteins; involved in the replication and maintenance of killer double stranded RNA virus
YDL075W Rpl31a 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl31Bp and has similarity to rat L31 ribosomal protein; associates with the karyopherin Sxm1p; loss of both Rpl31p and Rpl39p confers lethality
YPL143W Rpl33a 4 N-terminally acetylated ribosomal protein L37 of the large (60S) ribosomal subunit, nearly identical to Rpl33Bp and has similarity to rat L35a; rpl33a null mutant exhibits slow growth while rpl33a rpl33b double null mutant is inviable
YPL249C-A Rpl36b 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl36Ap and has similarity to rat L36 ribosomal protein; binds to 5.8 S rRNA
YBR031W Rpl4a 4 N-terminally acetylated protein component of the large (60S) ribosomal subunit, nearly identical to Rpl4Bp and has similarity to E. coli L4 and rat L4 ribosomal proteins
YPL131W Rpl5 4 Protein component of the large (60S) ribosomal subunit with similarity to E. coli L18 and rat L5 ribosomal proteins; binds 5S rRNA and is required for 60S subunit assembly
YML073C Rpl6a 4 N-terminally acetylated protein component of the large (60S) ribosomal subunit, has similarity to Rpl6Bp and to rat L6 ribosomal protein; binds to 5.8S rRNA
YGL076C Rpl7a 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl7Bp and has similarity to E. coli L30 and rat L7 ribosomal proteins; contains a conserved C-terminal Nucleic acid Binding Domain (NDB2)
YLR340W Rpp0 4 Conserved ribosomal protein P0 of the ribosomal stalk, which is involved in interaction between translational elongation factors and the ribosome; similar to rat P0, human P0, and E. coli L10e; phosphorylated on serine 302
YOR369C Rps12 4 Protein component of the small (40S) ribosomal subunit; has similarity to rat ribosomal protein S12
YCR031C Rps14a 4 Ribosomal protein 59 of the small subunit, required for ribosome assembly and 20S pre-rRNA processing; mutations confer cryptopleurine resistance; nearly identical to Rps14Bp and similar to E. coli S11 and rat S14 ribosomal proteins
YJL191W Rps14b 4 Ribosomal protein 59 of the small subunit, required for ribosome assembly and 20S pre-rRNA processing; mutations confer cryptopleurine resistance; nearly identical to Rps14Ap and similar to E. coli S11 and rat S14 ribosomal proteins
YOL040C Rps15 4 Protein component of the small (40S) ribosomal subunit; has similarity to E. coli S19 and rat S15 ribosomal proteins
YMR143W Rps16a 4 Protein component of the small (40S) ribosomal subunit; identical to Rps16Bp and has similarity to E. coli S9 and rat S16 ribosomal proteins
YDL083C Rps16b 4 Protein component of the small (40S) ribosomal subunit; identical to Rps16Ap and has similarity to E. coli S9 and rat S16 ribosomal proteins
YML024W Rps17a 4 Ribosomal protein 51 (rp51) of the small (40s) subunit; nearly identical to Rps17Bp and has similarity to rat S17 ribosomal protei
YDR447C Rps17b 4 Ribosomal protein 51 (rp51) of the small (40s) subunit; nearly identical to Rps17Ap and has similarity to rat S17 ribosomal protein
YDR450W Rps18a 4 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps18Bp and has similarity to E. coli S13 and rat S18 ribosomal proteins
YML026C Rps18b 4 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps18Ap and has similarity to E. coli S13 and rat S18 ribosomal proteins
YOL121C Rps19a 4 Protein component of the small (40S) ribosomal subunit, required for assembly and maturation of pre-40 S particles; mutations in human RPS19 are associated with Diamond Blackfan anemia; nearly identical to Rps19Bp
YNL302C Rps19b 4 Protein component of the small (40S) ribosomal subunit, required for assembly and maturation of pre-40 S particles; mutations in human RPS19 are associated with Diamond Blackfan anemia; nearly identical to Rps19Ap
YLR441C Rps1a 4 Ribosomal protein 10 (rp10) of the small (40S) subunit; nearly identical to Rps1Bp and has similarity to rat S3a ribosomal protein
YML063W Rps1b 4 Ribosomal protein 10 (rp10) of the small (40S) subunit; nearly identical to Rps1Ap and has similarity to rat S3a ribosomal protein
YGL123W Rps2 4 Protein component of the small (40S) subunit, essential for control of translational accuracy; phosphorylation by C-terminal domain kinase I (CTDK-I) enhances translational accuracy; methylated on one or more arginine residues by Hmt1p
YHL015W Rps20 4 Protein component of the small (40S) ribosomal subunit; overproduction suppresses mutations affecting RNA polymerase III-dependent transcription; has similarity to E. coli S10 and rat S20 ribosomal proteins
YNL178W Rps3 4 Protein component of the small (40S) ribosomal subunit, has apurinic/apyrimidinic (AP) endonuclease activity; essential for viability; has similarity to E. coli S3 and rat S3 ribosomal proteins
YJR145C Rps4a 4 Protein component of the small (40S) ribosomal subunit; mutation affects 20S pre-rRNA processing; identical to Rps4Bp and has similarity to rat S4 ribosomal protei
YHR203C Rps4b 4 Protein component of the small (40S) ribosomal subunit; identical to Rps4Ap and has similarity to rat S4 ribosomal protein
YJR123W Rps5 4 Protein component of the small (40S) ribosomal subunit, the least basic of the non-acidic ribosomal proteins; phosphorylated in vivo; essential for viability; has similarity to E. coli S7 and rat S5 ribosomal proteins
YBL072C Rps8a 4 Protein component of the small (40S) ribosomal subunit; identical to Rps8Bp and has similarity to rat S8 ribosomal protein
YER102W Rps8b 4 Protein component of the small (40S) ribosomal subunit; identical to Rps8Ap and has similarity to rat S8 ribosomal protein
YPL081W Rps9a 4 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps9Bp and has similarity to E. coli S4 and rat S9 ribosomal proteins
YBR189W Rps9b 4 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps9Ap and has similarity to E. coli S4 and rat S9 ribosomal proteins
YLR058C Shm2 4 Cytosolic serine hydroxymethyltransferase, converts serine to glycine plus 5,10 methylenetetrahydrofolate; major isoform involved in generating precursors for purine, pyrimidine, amino acid, and lipid biosynthesis
YLL024C Ssa2 4 ATP binding protein involved in protein folding and vacuolar import of proteins; member of heat shock protein 70 (HSP70) family; associated with the chaperonin-containing T-complex;
YNL209W Ssb2 4 Cytoplasmic ATPase that is a ribosome-associated molecular chaperone, functions with J-protein partner Zuo1p; may be involved in the folding of newly-synthesized polypeptide chains; member of the HSP70 family; homolog of SSB1
YLR150W Stm1 4 Protein required for optimal translation under nutrient stress; perturbs association of Yef3p with ribosomes; involved in TOR signaling; binds G4 quadruplex and purine motif triplex nucleic acid; helps maintain telomere structure
YPR080W Tef1 4 Translational elongation factor EF-1 alpha; also encoded by TEF2; functions in the binding reaction of aminoacyl-tRNA (AA-tRNA) to ribosomes; may also have a role in tRNA re-export from the nucleus
YBR118W Tef2 4 Translational elongation factor EF-1 alpha; also encoded by TEF1; functions in the binding reaction of aminoacyl-tRNA (AA-tRNA) to ribosomes; may also have a role in tRNA re-export from the nucleus
YLR249W Yef3 4 Gamma subunit of translational elongation factor eEF1B, stimulates the binding of aminoacyl-tRNA (AA-tRNA) to ribosomes by releasing eEF1A (Tef1p/Tef2p) from the ribosomal complex; contains two ABC cassettes; binds and hydrolyzes ATP
YFL039C Act1 3 Actin, structural protein involved in cell polarization, endocytosis, and other cytoskeletal functions
YOL139C Cdc33 3 Cytoplasmic mRNA cap binding protein and translation initiation factor eIF4E; the eIF4E-cap complex is responsible for mediating cap-dependent mRNA translation via interactions with translation initiation factor eIF4G (Tif4631p or Tif4632p
YNR001C Cit1 3 Citrate synthase, catalyzes the condensation of acetyl coenzyme A and oxaloacetate to form citrate; the rate-limiting enzyme of the TCA cycle; nuclear encoded mitochondrial protein
YOR204W Ded1 3 ATP-dependent DEAD (Asp-Glu-Ala-Asp)-box RNA helicase, required for translation initiation of all yeast mRNAs; mutations in human DEAD-box DBY are a frequent cause of male infertility
YLL018C Dps1 3 Aspartyl-tRNA synthetase, primarily cytoplasmic; homodimeric enzyme that catalyzes the specific aspartylation of tRNA(Asp); class II aminoacyl tRNA synthetase; binding to its own mRNA may confer autoregulation
YPL037C Egd1 3 Subunit beta1 of the nascent polypeptide-associated complex (NAC) involved in protein targeting, associated with cytoplasmic ribosomes; enhances DNA binding of the Gal4p activator; homolog of human BTF3b
YLR300W Exg1 3 Major exo-1,3-beta-glucanase of the cell wall, involved in cell wall beta-glucan assembly; exists as three differentially glycosylated isoenzymes
YBR009C Hhf1 3 Histone H4, core histone protein required for chromatin assembly and chromosome function; one of two identical histone proteins (see also HHF2); contributes to telomeric silencing; N-terminal domain involved in maintaining genomic integrity
YNL030W Hhf2 3 Histone H4, core histone protein required for chromatin assembly and chromosome function; one of two identical histone proteins (see also HHF1); contributes to telomeric silencing; N-terminal domain involved in maintaining genomic integrity
YMR186W Hsc82 3 Cytoplasmic chaperone of the Hsp90 family, redundant in function and nearly identical with Hsp82p, and together they are essential; expressed constitutively at 10-fold higher basal levels than HSP82 and induced 2-3 fold by heat shock
YLR259C Hsp60 3 Tetradecameric mitochondrial chaperonin required for ATP-dependent folding of precursor polypeptides and complex assembly; prevents aggregation and mediates protein refolding after heat shock; role in mtDNA transmission; phosphorylated
Table S1 part C (continued)
Fold found on 
ORF Protein SZMP-resin Protein function
name name (4 columns)
YPR033C Hts1 3 Cytoplasmic and mitochondrial histidine tRNA synthetase; efficient mitochondrial localization requires both a presequence and an amino-terminal sequence
YEL034W Hyp2 3 Translation elongation factor eIF-5A that may function in translation initiation; similar to and functionally redundant with Anb1p; structural homolog of bacterial EF-P; undergoes an essential hypusination modification
YLR432W Imd3 3 Inosine monophosphate dehydrogenase, catalyzes the first step of GMP biosynthesis, member of a four-gene family in S. cerevisiae, constitutively expressed
YML056C Imd4 3 Inosine monophosphate dehydrogenase, catalyzes the first step of GMP biosynthesis, member of a four-gene family in S. cerevisiae, constitutively expressed
YDR037W Krs1 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl12Ap; rpl12a rpl12b double mutant exhibits slow growth and slow translation; has similarity to E. coli L11 and rat L12 ribosomal proteins
YDL051W Lhp1 3 RNA binding protein required for maturation of tRNA and U6 snRNA precursors; acts as a molecular chaperone for RNAs transcribed by polymerase III
YPL004C Lsp1 3 Primary component of eisosomes, which are large immobile patch structures at the cell cortex associated with endocytosis, along with Pil1p and Sur7p; null mutants show activation of Pkc1p/Ypk1p stress resistance pathways; member of the BAR domain family
YKL009W Mrt4 3 Protein involved in mRNA turnover and ribosome assembly, localizes to the nucleolus
YDL014W Nop1 3 Nucleolar protein, component of the small subunit processome complex, which is required for processing of pre-18S rRNA; has similarity to mammalian fibrillarin
YGR159C Nsr1 3 Nucleolar protein that binds nuclear localization sequences, required for pre-rRNA processing and ribosome biogenesis
YER165W Pab1 3 Poly(A) binding protein, part of the 3'-end RNA-processing complex, mediates interactions between the 5' cap structure and the 3' mRNA poly(A) tail, involved in control of poly(A) tail length, interacts with translation factor eIF-4G
YGR086C Pil1 3 Primary component of eisosomes, which are large immobile cell cortex structures associated with endocytosis; null mutants show activation of Pkc1p/Ypk1p stress resistance pathways
YGL008C Pma1 3 Plasma membrane H+-ATPase, pumps protons out of the cell; major regulator of cytoplasmic pH and plasma membrane potential; P2-type ATPase; Hsp30p plays a role in Pma1p regulation; interactions with Std1p appear to propagate [GAR+]
YLR196W Pwp1 3 Protein with WD-40 repeats involved in rRNA processing; associates with trans-acting ribosome biogenesis factors; similar to beta-transducin superfamily
YEL054C Rpl12a 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl12Bp; rpl12a rpl12b double mutant exhibits slow growth and slow translation; has similarity to E. coli L11 and rat L12 ribosomal proteins
YDR418W Rpl12b 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl12Ap; rpl12a rpl12b double mutant exhibits slow growth and slow translation; has similarity to E. coli L11 and rat L12 ribosomal proteins
YDL082W Rpl13a 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl13Bp; not essential for viability; has similarity to rat L13 ribosomal protein
YLR029C Rpl15a 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl15Bp and has similarity to rat L15 ribosomal protein; binds to 5.8 S rRNA
YJL177W Rpl17b 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl17Ap and has similarity to E. coli L22 and rat L17 ribosomal proteins
YOL120C Rpl18a 3 Protein component of the large (60S) ribosomal subunit, identical to Rpl18Bp and has similarity to rat L18 ribosomal protein; intron of RPL18A pre-mRNA forms stem-loop structures that are a target for Rnt1p cleavage leading to degradation
YNL301C Rpl18b 3 Protein component of the large (60S) ribosomal subunit, identical to Rpl18Ap and has similarity to rat L18 ribosomal protein
YBR191W Rpl21a 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl21Bp and has similarity to rat L21 ribosomal protein
YPL079W Rpl21b 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl21Ap and has similarity to rat L21 ribosomal protein
YGL031C Rpl24a 3 Ribosomal protein L30 of the large (60S) ribosomal subunit, nearly identical to Rpl24Bp and has similarity to rat L24 ribosomal protein; not essential for translation but may be required for normal translation rate
YGR148C Rpl24b 3 Ribosomal protein L30 of the large (60S) ribosomal subunit, nearly identical to Rpl24Ap and has similarity to rat L24 ribosomal protein; not essential for translation but may be required for normal translation rate
YOL127W Rpl25 3 Primary rRNA-binding ribosomal protein component of the large (60S) ribosomal subunit, has similarity to E. coli L23 and rat L23a ribosomal proteins; binds to 25S rRNA via a conserved C-terminal motif
YLR344W Rpl26a 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl26Bp and has similarity to E. coli L24 and rat L26 ribosomal proteins; binds to 5.8S rRNA
YFR031C-A Rpl2a 3 Protein component of the large (60S) ribosomal subunit, identical to Rpl2Bp and has similarity to E. coli L2 and rat L8 ribosomal proteins
YIL018W Rpl2b 3 Protein component of the large (60S) ribosomal subunit, identical to Rpl2Ap and has similarity to E. coli L2 and rat L8 ribosomal proteins; expression is upregulated at low temperatures
YBL092W Rpl32 3 Protein component of the large (60S) ribosomal subunit, has similarity to rat L32 ribosomal protein; overexpression disrupts telomeric silencing
YOR234C Rpl33b 3 Ribosomal protein L37 of the large (60S) ribosomal subunit, nearly identical to Rpl33Ap and has similarity to rat L35a; rpl33b null mutant exhibits normal growth while rpl33a rpl33b double null mutant is inviable
YMR194W Rpl36a 3 N-terminally acetylated protein component of the large (60S) ribosomal subunit, nearly identical to Rpl36Bp and has similarity to rat L36 ribosomal protein; binds to 5.8 S rRNA
YDR012W Rpl4b 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl4Ap and has similarity to E. coli L4 and rat L4 ribosomal proteins
YHL033C Rpl8a 3 Ribosomal protein L4 of the large (60S) ribosomal subunit, nearly identical to Rpl8Bp and has similarity to rat L7a ribosomal protein; mutation results in decreased amounts of free 60S subunits
YLL045C Rpl8b 3 Ribosomal protein L4 of the large (60S) ribosomal subunit, nearly identical to Rpl8Ap and has similarity to rat L7a ribosomal protein; mutation results in decreased amounts of free 60S subunits
YER074W Rps24a 3 Protein component of the small (40S) ribosomal subunit; identical to Rps24Bp and has similarity to rat S24 ribosomal protein
YIL069C Rps24b 3 Protein component of the small (40S) ribosomal subunit; identical to Rps24Ap and has similarity to rat S24 ribosomal protein
YGR027C Rps25a 3 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps25Bp and has similarity to rat S25 ribosomal protein
YLR333C Rps25b 3 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps25Ap and has similarity to rat S25 ribosomal protein
YOR167C Rps28a 3 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps28Bp and has similarity to rat S28 ribosomal protein
YLR264W Rps28b 3 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps28Ap and has similarity to rat S28 ribosomal protein
YPL090C Rps6a 3 Protein component of the small (40S) ribosomal subunit; identical to Rps6Bp and has similarity to rat S6 ribosomal protein
YBR181C Rps6b 3 Protein component of the small (40S) ribosomal subunit; identical to Rps6Ap and has similarity to rat S6 ribosomal protein
YNL096C Rps7b 3 Protein component of the small (40S) ribosomal subunit, nearly identical to Rps7Ap; interacts with Kti11p; deletion causes hypersensitivity to zymocin; has similarity to rat S7 and Xenopus S8 ribosomal proteins
YHL034C Sbp1 3 Putative RNA binding protein; involved in translational repression and found in cytoplasmic P bodies; found associated with small nucleolar RNAs snR10 and snR11
YDR023W Ses1 3 Cytosolic seryl-tRNA synthetase, class II aminoacyl-tRNA synthetase that aminoacylates tRNA(Ser), displays tRNA-dependent amino acid recognition which enhances discrimination of the serine substrate, interacts with peroxin Pex21p
YDL229W Ssb1 3 Cytoplasmic ATPase that is a ribosome-associated molecular chaperone, functions with J-protein partner Zuo1p; may be involved in folding of newly-made polypeptide chains
YHR064C Ssz1 3 Hsp70 protein that interacts with Zuo1p (a DnaJ homolog) to form a ribosome-associated complex that binds the ribosome via the Zuo1p subunit; also involved in pleiotropic drug resistance via sequential activation of PDR1 and PDR5; binds ATP
YPL237W Sui3 3 Beta subunit of the translation initiation factor eIF2, involved in the identification of the start codon; proposed to be involved in mRNA binding
YIL078W Ths1 3 Threonyl-tRNA synthetase, essential cytoplasmic protein
YMR260C Tif11 3 Translation initiation factor eIF1A, essential protein that forms a complex with Sui1p (eIF1) and the 40S ribosomal subunit and scans for the start codon; C-terminus associates with Fun12p (eIF5B); N terminus interacts with eIF2 and eIF3
YKL035W Ugp1 3 UDP-glucose pyrophosphorylase (UGPase), catalyses the reversible formation of UDP-Glc from glucose 1-phosphate and UTP, involved in a wide variety of metabolic pathways, expression modulated by Pho85p through Pho4p
YDL185W Vma1 3 Subunit A of the eight-subunit V1 peripheral membrane domain of the vacuolar H+-ATPase; protein precursor undergoes self-catalyzed splicing to yield the extein Tfp1p and the intein Vde (PI-SceI), which is a site-specific endonuclease
YBR127C Vma2 3 Subunit B of the eight-subunit V1 peripheral membrane domain of the vacuolar H+-ATPase (V-ATPase), an electrogenic proton pump found throughout the endomembrane system; contains nucleotide binding sites
YGR285C Zuo1 3 Ribosome-associated chaperone, functions in ribosome biogenesis and, in partnership with Ssz1p and SSb1/2, as a chaperone for nascent polypeptide chains
Table S1 part D : List of proteins bound to  AICAR-affinity resin at least three times on 5 independent experiments
Fold found on 
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YAL003W Efb1 5 Translation elongation factor 1 beta; stimulates nucleotide exchange to regenerate EF-1 alpha-GTP for the next elongation cycle; part of the EF-1 complex, which facilitates binding of aminoacyl-tRNA to the ribosomal A site
YLR300W Exg1 5 Major exo-1,3-beta-glucanase of the cell wall, involved in cell wall beta-glucan assembly; exists as three differentially glycosylated isoenzymes
YEL034W Hyp2 5 Translation elongation factor eIF-5A that may function in translation initiation; similar to and functionally redundant with Anb1p; structural homolog of bacterial EF-P; undergoes an essential hypusination modification
YLR432W Imd3 5 Inosine monophosphate dehydrogenase, catalyzes the first step of GMP biosynthesis, member of a four-gene family in S. cerevisiae, constitutively expressed
YML056C Imd4 5 Inosine monophosphate dehydrogenase, catalyzes the first step of GMP biosynthesis, member of a four-gene family in S. cerevisiae, constitutively expressed
YER165W Pab1 5 Poly(A) binding protein, part of the 3'-end RNA-processing complex, mediates interactions between the 5' cap structure and the 3' mRNA poly(A) tail, involved in control of poly(A) tail length, interacts with translation factor eIF-4G
YGL037C Pnc1 5 Nicotinamidase that converts nicotinamide to nicotinic acid as part of the NAD(+) salvage pathway, required for life span extension by calorie restriction; PNC1 expression responds to all known stimuli that extend replicative life span
YOR369C Rps12 5 Protein component of the small (40S) ribosomal subunit; has similarity to rat ribosomal protein S12
YHL015W Rps20 5 Protein component of the small (40S) ribosomal subunit; overproduction suppresses mutations affecting RNA polymerase III-dependent transcription; has similarity to E. coli S10 and rat S20 ribosomal proteins
YHL034C Sbp1 5 Putative RNA binding protein; involved in translational repression and found in cytoplasmic P bodies; found associated with small nucleolar RNAs snR10 and snR11
YDR023W Ses1 5 Cytosolic seryl-tRNA synthetase, class II aminoacyl-tRNA synthetase that aminoacylates tRNA(Ser), displays tRNA-dependent amino acid recognition which enhances discrimination of the serine substrate, interacts with peroxin Pex21p
YDL229W Ssb1 5 Cytoplasmic ATPase that is a ribosome-associated molecular chaperone, functions with J-protein partner Zuo1p; may be involved in folding of newly-made polypeptide chains; member of the HSP70 family; interacts with phosphatase subunit Reg1p
YNL209W Ssb2 5 Cytoplasmic ATPase that is a ribosome-associated molecular chaperone, functions with J-protein partner Zuo1p; may be involved in the folding of newly-synthesized polypeptide chains; member of the HSP70 family; homolog of SSB1
YLR150W Stm1 5 Protein required for optimal translation under nutrient stress; perturbs association of Yef3p with ribosomes; involved in TOR signaling; binds G4 quadruplex and purine motif triplex nucleic acid; helps maintain telomere structure
YHR019C Ded81 4 Cytosolic asparaginyl-tRNA synthetase, required for protein synthesis, catalyzes the specific attachment of asparagine to its cognate tRNA
YOR133W Eft1 4 Elongation factor 2 (EF-2), also encoded by EFT2; catalyzes ribosomal translocation during protein synthesis; contains diphthamide, the unique posttranslationally modified histidine residue specifically ADP-ribosylated by diphtheria toxin
YDR385W Eft2 4 Elongation factor 2 (EF-2), also encoded by EFT1; catalyzes ribosomal translocation during protein synthesis; contains diphthamide, the unique posttranslationally modified histidine residue specifically ADP-ribosylated by diphtheria toxin
YPL037C Egd1 4 Subunit beta1 of the nascent polypeptide-associated complex (NAC) involved in protein targeting, associated with cytoplasmic ribosomes; enhances DNA binding of the Gal4p activator; homolog of human BTF3b
YOL123W Hrp1 4 Subunit of cleavage factor I, a five-subunit complex required for the cleavage and polyadenylation of pre-mRNA 3' ends; RRM-containing heteronuclear RNA binding protein and hnRNPA/B family member that binds to poly (A) signal sequences
YLR259C Hsp60 4 Tetradecameric mitochondrial chaperonin required for ATP-dependent folding of precursor polypeptides and complex assembly; prevents aggregation and mediates protein refolding after heat shock; role in mtDNA transmission; phosphorylated
YDL051W Lhp1 4 RNA binding protein required for maturation of tRNA and U6 snRNA precursors; acts as a molecular chaperone for RNAs transcribed by polymerase III; homologous to human La (SS-B) autoantigen
YDR432W Npl3 4 RNA binding protein required for maturation of tRNA and U6 snRNA precursors; acts as a molecular chaperone for RNAs transcribed by polymerase III; homologous to human La (SS-B) autoantigen
YPR102C Rpl11a 4 Protein of the large 60S ribosomal subunit, nearly identical to Rpl11Bp but expressed at twice the level; involved in ribosomal assembly; depletion causes degradation of 60S proteins and RNA; similar to E. coli L5 and rat L11
YGR085C Rpl11b 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl11Ap; involved in ribosomal assembly; depletion causes degradation of proteins and RNA of the 60S subunit; has similarity to E. coli L5 and rat L11
YGR034W Rpl26b 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl26Ap and has similarity to E. coli L24 and rat L26 ribosomal proteins; binds to 5.8S rRNA
YDL075W Rpl31a 4 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl31Bp and has similarity to rat L31 ribosomal protein; associates with the karyopherin Sxm1p; loss of both Rpl31p and Rpl39p confers lethality
YPL131W Rpl5 4 Protein component of the large (60S) ribosomal subunit with similarity to E. coli L18 and rat L5 ribosomal proteins; binds 5S rRNA and is required for 60S subunit assembly
YML024W Rps17a 4 Ribosomal protein 51 (rp51) of the small (40s) subunit; nearly identical to Rps17Bp and has similarity to rat S17 ribosomal prote
YDR447C Rps17b 4 Ribosomal protein 51 (rp51) of the small (40s) subunit; nearly identical to Rps17Ap and has similarity to rat S17 ribosomal protein
YOL121C Rps19a 4 Protein component of the small (40S) ribosomal subunit, required for assembly and maturation of pre-40 S particles; mutations in human RPS19 are associated with Diamond Blackfan anemia; nearly identical to Rps19Bp
YNL302C Rps19b 4 Protein component of the small (40S) ribosomal subunit, required for assembly and maturation of pre-40 S particles; mutations in human RPS19 are associated with Diamond Blackfan anemia; nearly identical to Rps19Ap
YNL178W Rps3 4 Protein component of the small (40S) ribosomal subunit, has apurinic/apyrimidinic (AP) endonuclease activity; essential for viability; has similarity to E. coli S3 and rat S3 ribosomal proteins
YJR123W Rps5 4 Protein component of the small (40S) ribosomal subunit, the least basic of the non-acidic ribosomal proteins; phosphorylated in vivo; essential for viability; has similarity to E. coli S7 and rat S5 ribosomal proteins
YBR118W Tef2 4 Translational elongation factor EF-1 alpha; also encoded by TEF1; functions in the binding reaction of aminoacyl-tRNA (AA-tRNA) to ribosomes; may also have a role in tRNA re-export from the nucleu
YIL078W Ths1 4 Threonyl-tRNA synthetase, essential cytoplasmic protein
YPR163C Tif3 4 Translation initiation factor eIF-4B, has RNA annealing activity; contains an RNA recognition motif and binds to single-stranded RNA
YFL039C Act1 3 Actin, structural protein involved in cell polarization, endocytosis, and other cytoskeletal functions
YMR116C Asc1 3 G-protein beta subunit and guanine nucleotide dissociation inhibitor for Gpa2p; ortholog of RACK1 that inhibits translation; core component of the small (40S) ribosomal subunit; represses Gcn4p in the absence of amino acid starvation
YAL038W Cdc19 3 Pyruvate kinase, functions as a homotetramer in glycolysis to convert phosphoenolpyruvate to pyruvate, the input for aerobic (TCA cycle) or anaerobic (glucose fermentation) respiration
YLL018C Dps1 3 Aspartyl-tRNA synthetase, primarily cytoplasmic; homodimeric enzyme that catalyzes the specific aspartylation of tRNA(Asp); class II aminoacyl tRNA synthetase; binding to its own mRNA may confer autoregulation
YHR193C Egd2 3 Alpha subunit of the heteromeric nascent polypeptide-associated complex (NAC) involved in protein sorting and translocation, associated with cytoplasmic ribosomes
YGR200C Elp2 3 Subunit of Elongator complex, which is required for modification of wobble nucleosides in tRNA; target of Kluyveromyces lactis zymocin
YER025W Gcd11 3 Gamma subunit of the translation initiation factor eIF2, involved in the identification of the start codon; binds GTP when forming the ternary complex with GTP and tRNAi-Met
YER133W Glc7 3 Type 1 serine/threonine protein phosphatase catalytic subunit, involved in many processes (eg: glycogen metabolism, sporulation, mitosis); accumulates at mating projections by interaction with Afr1p; interacts with many regulatory subunits
YMR186W Hsc82 3 Cytoplasmic chaperone of the Hsp90 family, redundant in function and nearly identical with Hsp82p, and together they are essential; expressed constitutively at 10-fold higher basal levels than HSP82 and induced 2-3 fold by heat shock
YPL240C Hsp82 3 Hsp90 chaperone required for pheromone signaling and negative regulation of Hsf1p; docks with Tom70p for mitochondrial preprotein delivery; promotes telomerase DNA binding and nucleotide addition; interacts with Cns1p, Cpr6p, Cpr7p, Sti1p
YDR037W Krs1 3 Lysyl-tRNA synthetase
YPL004C Lsp1 3 Primary component of eisosomes, which are large immobile patch structures at the cell cortex associated with endocytosis, along with Pil1p and Sur7p
YLR044C Pdc1 3 Major of three pyruvate decarboxylase isozymes, key enzyme in alcoholic fermentation, decarboxylates pyruvate to acetaldehyde; subject to glucose-, ethanol-, and autoregulation; involved in amino acid catabolism
YLR406C Rpl31b 3 Protein component of the large (60S) ribosomal subunit, nearly identical to Rpl31Ap and has similarity to rat L31 ribosomal protein; associates with the karyopherin Sxm1p; loss of both Rpl31p and Rpl39p confers lethality
YLR448W Rpl6b 3 Protein component of the large (60S) ribosomal subunit, has similarity to Rpl6Ap and to rat L6 ribosomal protein; binds to 5.8S rRNA
YOL039W Rpp2a 3 Ribosomal protein P2 alpha, a component of the ribosomal stalk, which is involved in the interaction between translational elongation factors and the ribosome; regulates the accumulation of P1 (Rpp1Ap and Rpp1Bp) in the cytoplasm
YDR382W Rpp2b 3 Ribosomal protein P2 beta, a component of the ribosomal stalk, which is involved in the interaction between translational elongation factors and the ribosome; regulates the accumulation of P1 (Rpp1Ap and Rpp1Bp) in the cytoplasm
YGR214W Rps0a 3 Protein component of the small (40S) ribosomal subunit, nearly identical to Rps0Bp; required for maturation of 18S rRNA along with Rps0Bp; deletion of either RPS0 gene reduces growth rate, deletion of both genes is lethal
YLR048W Rps0b 3 Protein component of the small (40S) ribosomal subunit, nearly identical to Rps0Ap; required for maturation of 18S rRNA along with Rps0Ap; deletion of either RPS0 gene reduces growth rate, deletion of both genes is lethal
YOR167C Rps28a 3 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps28Bp and has similarity to rat S28 ribosomal protein
YLR264W Rps28b 3 Protein component of the small (40S) ribosomal subunit; nearly identical to Rps28Ap and has similarity to rat S28 ribosomal protein
YPR181C Sec23 3 GTPase-activating protein, stimulates the GTPase activity of Sar1p; component of the Sec23p-Sec24p heterodimer of the COPII vesicle coat, involved in ER to Golgi transport
YLL024C Ssa2 3 ATP binding protein involved in protein folding and vacuolar import of proteins; member of heat shock protein 70 (HSP70) family
YJR007W Sui2 3 Alpha subunit of the translation initiation factor eIF2, involved in the identification of the start codon; phosphorylation of Ser51 is required for regulation of translation by inhibiting the exchange of GDP for GTP
YJR009C Tdh2 3 Glyceraldehyde-3-phosphate dehydrogenase, isozyme 2, involved in glycolysis and gluconeogenesis; tetramer that catalyzes the reaction of glyceraldehyde-3-phosphate to 1,3 bis-phosphoglycerate; detected in the cytoplasm and cell wall
YGR192C Tdh3 3 Glyceraldehyde-3-phosphate dehydrogenase, isozyme 3, involved in glycolysis and gluconeogenesis; tetramer that catalyzes the reaction of glyceraldehyde-3-phosphate to 1,3 bis-phosphoglycerate; detected in the cytoplasm and cell wall
YPR080W Tef1 3 Translational elongation factor EF-1 alpha; also encoded by TEF2; functions in the binding reaction of aminoacyl-tRNA (AA-tRNA) to ribosomes; may also have a role in tRNA re-export from the nucleus
YKR059W Tif1 3 Translation initiation factor eIF4A, identical to Tif2p; DEA(D/H)-box RNA helicase that couples ATPase activity to RNA binding and unwinding; forms a dumbbell structure of two compact domains connected by a linker; interacts with eIF4G
YJL138C Tif2 3 Translation initiation factor eIF4A, identical to Tif1p; DEA(D/H)-box RNA helicase that couples ATPase activity to RNA binding and unwinding; forms a dumbbell structure of two compact domains connected by a linker; interacts with eIF4G
YLR262C-A Tma7 3 Protein of unknown that associates with ribosomes; null mutant exhibits translation defects, altered polyribosome profiles, and resistance to the translation inhibitor anisomcyin
YDL185W Vma1 3 Subunit A of the eight-subunit V1 peripheral membrane domain of the vacuolar H+-ATPase; protein precursor undergoes self-catalyzed splicing to yield the extein Tfp1p and the intein Vde (PI-SceI), which is a site-specific endonuclease
YLR249W Yef3 3 Gamma subunit of translational elongation factor eEF1B, stimulates the binding of aminoacyl-tRNA (AA-tRNA) to ribosomes by releasing eEF1A (Tef1p/Tef2p) from the ribosomal complex; contains two ABC cassettes; binds and hydrolyzes ATP
YHR020W Yhr020w 3 Protein of unknown function that may interact with ribosomes, based on co-purification experiments; has similarity to proline-tRNA ligase; YHR020W is an essential gene
Table S2: List of the 57 proteins less abundant  in the presence of AICAR 
Mean Mean T-test
Protein Protein abundance abundance Ratio p-value
Name Function + AICAR - AICAR + vs - AICAR + vs - AICAR
Btn2 v-SNARE binding protein 5.5E+05 2.7E+06 0.20 0.010
Crz1 Transcription factor 8.3E+05 3.3E+06 0.25 0.043
Snu13 RNA binding protein; part of U3 snoRNP 2.8E+06 1.1E+07 0.25 0.022
Hhf1 Histone H4 5.2E+07 2.0E+08 0.26 0.041
Srp40 Role in preribosome assembly or transport 4.5E+06 1.7E+07 0.26 0.029
Htb2 Histone H2B 2.0E+06 7.8E+06 0.26 0.004
Dep1 Component of the Rpd3L histone deacetylase complex 4.3E+05 1.6E+06 0.28 0.002
Isw1 ATPase subunit of imitation-switch  chromatin remodelers 2.5E+06 8.2E+06 0.31 0.012
Htz1 Histone variant H2AZ 9.8E+06 3.1E+07 0.31 0.022
Rpo31 RNA polymerase III largest subunit C160 1.1E+05 3.6E+05 0.32 0.035
Abf1 DNA binding protein with possible chromatin-reorganizing activity 6.0E+06 1.9E+07 0.32 0.034
Spc110 Inner plaque spindle pole body (SPB) component 3.2E+06 9.9E+06 0.32 0.046
Hta1 Histone H2A 2.2E+08 6.6E+08 0.33 0.006
Pho2 Homeobox transcription factor 7.7E+05 2.3E+06 0.33 0.012
Imp2' Transcriptional activator 5.4E+04 1.6E+05 0.34 0.013
Hht1 Histone H3 1.5E+07 4.4E+07 0.34 0.031
Tub4 Gamma-tubulin 3.4E+05 9.9E+05 0.34 0.035
Mcr1  NADH-cytochrome b5 reductase 2.1E+06 6.0E+06 0.35 0.040
Srm1 Nucleotide exchange factor for Gsp1p 1.3E+07 3.8E+07 0.35 0.018
Nit2 Nit protein 2.9E+05 8.1E+05 0.35 0.031
Tfa1 TFIIE large subunit 2.4E+06 6.9E+06 0.35 0.037
Hho1 Histone H1 7.5E+06 2.0E+07 0.37 0.046
Pxr1 Essential protein involved in rRNA and snoRNA maturation 7.4E+06 2.0E+07 0.37 0.009
Mot1 Essential protein involved in regulation of transcription 9.7E+07 2.5E+08 0.39 0.023
Taf7 TFIID subunit  involved in RNA polymerase II transcription 3.8E+06 9.7E+06 0.39 0.010
Raf1 Anti-repressor that increases 2 micron plasmid copy number 3.1E+06 8.0E+06 0.39 0.010
Ylr455w Component of the NuA3b histone acetyltransferase complex 2.9E+06 7.4E+06 0.40 0.008
Nop8 Nucleolar protein required for 60S ribosomal subunit biogenesis 3.0E+05 7.4E+05 0.40 0.049
Mpp10 Component of the SSU processome and 90S preribosome 9.3E+05 2.3E+06 0.40 0.004
Rpb4 RNA polymerase II subunit B32 1.3E+06 3.3E+06 0.41 0.007
Rep2 Master regulator that regulates transcript levels of the FLP1 gene 8.0E+06 1.9E+07 0.41 0.009
Rpc34 RNA polymerase III subunit C34 2.0E+06 4.9E+06 0.42 0.040
Gcg1 Gamma-glutamyl cyclotransferase 3.4E+06 8.0E+06 0.42 0.005
Arp5 Nuclear actin-related protein involved in chromatin remodeling 2.7E+06 6.4E+06 0.43 0.016
Rap1 DNA-binding protein involved in  regulation of transcription 6.9E+06 1.6E+07 0.43 0.020
Nop56 Essential nucleolar protein 1.2E+08 2.9E+08 0.43 0.014
Scp1 Component of yeast cortical actin cytoskeleton 7.1E+05 1.6E+06 0.43 0.024
Fpr3 Nucleolar peptidyl-prolyl cis-trans isomerase (PPIase) 5.2E+07 1.2E+08 0.44 0.009
Rpc82 RNA polymerase III subunit C82 3.9E+06 8.8E+06 0.44 0.011
Tfc3 Subunit of the RNA polymerase III transcription initiation factor complex 2.6E+06 5.8E+06 0.45 0.007
Tfg2 TFIIF (Transcription Factor II) middle subunit 1.0E+06 2.3E+06 0.46 0.017
Nop7 Nucleolar protein involved in rRNA processing 3.3E+06 7.3E+06 0.46 0.012
Esf2 Essential nucleolar protein involved in pre-18S rRNA processing 5.0E+05 1.1E+06 0.46 0.046
Nop6 rRNA-binding protein required for 40S ribosomal subunit biogenesis 4.4E+06 9.5E+06 0.46 0.008
Itc1 Subunit of the ATP-dependent Isw2p-Itc1p chromatin remodeling complex 3.3E+06 7.2E+06 0.46 0.021
Rpc25 RNA polymerase III subunit C25 1.6E+06 3.4E+06 0.47 0.010
Bdf1 Protein involved in transcription initiation at TATA-containing promoters 3.6E+06 7.8E+06 0.47 0.033
Rcm1 rRNA m5C methyltransferase 5.9E+05 1.2E+06 0.47 0.028
Rxt3 Subunit of the RPD3L complex 1.1E+06 2.3E+06 0.47 0.012
Mip1 Catalytic subunit of the mitochondrial DNA polymerase 6.2E+05 1.3E+06 0.47 0.013
Cyc2 Mitochondrial peripheral inner membrane protein 5.3E+05 1.1E+06 0.48 0.032
Sen1 Helicase required for RNA polymerase II transcription 2.1E+06 4.3E+06 0.49 0.015
Arp4 Nuclear actin-related protein involved in chromatin remodeling 9.0E+06 1.8E+07 0.49 0.011
Rpa49 RNA polymerase I subunit A49 9.9E+06 2.0E+07 0.49 0.038
Noc2 Protein that forms a nucleolar complex with Mak21p 4.4E+06 9.1E+06 0.49 0.010
Rgd1 GTPase-activating protein for Rho3p and Rho4p, 1.9E+06 3.9E+06 0.50 0.006
Swc4 Component of the Swr1p complex 1.1E+06 2.2E+06 0.50 0.002
Table S3: GO term analyses for  the 57 proteins less abundant  in the presence of AICAR 
Fold
Biological process Enrichment p-Value 
Chromatin assembly 16.07 8.15E-05 4.0888424
Chromatin organization 7.04 2.05E-07 6.6882461
rRNA metabolic process 5.91 1.22E-04 3.9136402
Transcription, DNA-templated 5.67 5.73E-10 9.2418454
Regulation of biosynthetic process 3.6 7.75E-06 5.1106983
Fold
Cellular component Enrichment p-Value 
Nuclear nucleosome 100 5.03E-10 9.298432
Nuclear chromatin 13.73 9.31E-11 10.03105
Nuclear chromosome 6.97 7.16E-08 7.145087
Nuclear lumen 5.9 1.98E-20 19.703335
Nucleolus 5.55 7.70E-04 3.1135093
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 Table S4: List of the 92 proteins  more abundant when Kap123 is overexpressed
Mean Mean T-test
Protein Protein abundance abundance Ratio p-value
Name Function + AICAR - AICAR + vs - AICAR + vs - AICAR
Tkl2 Transketolase 2.40E+06 4.57E+05 5.25 0.024
Mcm2 Protein involved in DNA replication 1.89E+06 4.16E+05 4.53 0.044
Vps72 Htz1p-binding component of the SWR1 complex 7.31E+05 1.65E+05 4.42 0.048
Tfc6 Subunit of RNA polymerase III transcription initiation factor complex 2.29E+06 5.43E+05 4.21 0.025
Lam1 Putative sterol transfer protein 4.00E+05 1.03E+05 3.87 0.026
Vps1 Dynamin-like GTPase 1.80E+08 4.67E+07 3.86 0.034
Orc2 Subunit of the origin recognition complex, 6.97E+05 1.91E+05 3.65 0.039
Htz1 Histone variant H2AZ 3.52E+07 9.79E+06 3.59 0.049
Rtg3 Basic helix-loop-helix-leucine zipper transcription factor 5.45E+06 1.53E+06 3.56 0.044
Urb2 Protein required for metabolism of the rRNA primary transcript 5.01E+05 1.42E+05 3.53 0.047
Elc1 Elongin C 1.33E+06 3.79E+05 3.51 0.027
Htb2 Histone H2B 4.69E+06 1.36E+06 3.45 0.032
Pop1 Subunit of both RNase MRP and nuclear RNase P 3.34E+06 9.86E+05 3.39 0.039
Hos3 Trichostatin A-insensitive homodimeric histone deacetylase 9.85E+06 2.92E+06 3.37 0.022
Ams1 Vacuolar alpha mannosidase 1.16E+06 3.53E+05 3.27 0.047
Rod1 Alpha-arrestin involved in ubiquitin-dependent endocytosis 1.00E+06 3.14E+05 3.20 0.014
Isw1 ATPase subunit of imitation-switch  chromatin remodelers 9.98E+06 3.13E+06 3.19 0.050
Hsp30 Negative regulator of the H(+)-ATPase Pma1p 2.50E+07 8.15E+06 3.06 0.017
Yaf9 Subunit of NuA4 histone H4 acetyltransferase and SWR1 complexes 1.53E+06 5.01E+05 3.05 0.019
Noc3 Subunit of the nuclear Noc2p complex and pre-replicative complexes 7.98E+06 2.62E+06 3.04 0.014
Uls1 Swi2/Snf2-related translocase, SUMO-Targeted Ubiquitin Ligase 3.50E+05 1.18E+05 2.96 0.001
Epl1 Subunit of NuA4,  histone H4/H2A acetyltransferase complex 2.62E+06 8.89E+05 2.95 0.033
Hfi1 Adaptor protein required for structural integrity of the SAGA complex 1.55E+06 5.28E+05 2.94 0.002
Tfc4 Subunit of RNA polymerase III transcription initiation factor complex 1.22E+06 4.17E+05 2.92 0.013
Ask10 Component of RNA polymerase II holoenzyme 4.23E+06 1.52E+06 2.78 0.017
Lsp1 Primary component of eisosomes 4.70E+08 1.70E+08 2.76 0.015
Swc4 Component of the Swr1p complex 3.82E+06 1.40E+06 2.72 0.000
Pde1 Low-affinity cyclic AMP phosphodiesterase 1.24E+06 4.57E+05 2.72 0.016
Rap1 DNA-binding protein involved in  regulation of transcription 1.52E+07 5.66E+06 2.69 0.011
Pdc2 Transcription factor required for  synthesis of pyruvate decarboxylase 1.44E+06 5.39E+05 2.67 0.022
Pma1 Plasma membrane H+-ATPase 3.14E+07 1.18E+07 2.66 0.046
Sds3 Component of the Rpd3p/Sin3p deacetylase complex 1.19E+06 4.50E+05 2.64 0.023
Nde1 Mitochondrial external NADH dehydrogenase, 2.27E+06 8.64E+05 2.63 0.026
Dbp10 Putative ATP-dependent RNA helicase 3.39E+06 1.30E+06 2.61 0.047
Rad7 Nucleotide excision repair (NER) protein 2.69E+06 1.05E+06 2.56 0.042
Mec1 Genome integrity checkpoint protein, PI kinase superfamily member 4.21E+05 1.66E+05 2.53 0.024
Eaf1 Component of the NuA4 histone acetyltransferase complex 2.24E+06 8.96E+05 2.50 0.026
Fpr4 Peptidyl-prolyl cis-trans isomerase 7.31E+07 2.93E+07 2.49 0.008
Gph1 Non-essential glycogen phosphorylase 8.88E+06 3.58E+06 2.48 0.008
Arp5 Nuclear actin-related protein involved in chromatin remodeling 9.55E+06 3.87E+06 2.47 0.014
Spc110 Inner plaque spindle pole body (SPB) component 3.80E+06 1.54E+06 2.46 0.019
Suv3 ATP-dependent RNA helicase 1.57E+06 6.38E+05 2.46 0.009
Hxk1 Hexokinase isoenzyme 1 7.55E+05 3.09E+05 2.45 0.008
Mot1 Essential abundant protein involved in regulation of transcription 6.78E+06 2.79E+06 2.43 0.009
Ctt1 Cytosolic catalase T 9.20E+06 3.79E+06 2.43 0.001
Ykl023w Putative protein of unknown function 5.93E+06 2.47E+06 2.40 0.030
Mak5 Essential nucleolar protein; putative DEAD-box RNA helicase 1.28E+06 5.34E+05 2.39 0.005
Ald3 Cytoplasmic aldehyde dehydrogenase 2.38E+07 9.98E+06 2.38 0.045
Top1 Topoisomerase I 1.95E+07 8.24E+06 2.36 0.040
Arp4 Nuclear actin-related protein involved in chromatin remodeling 2.22E+07 9.41E+06 2.36 0.016
Fpr3 Nucleolar peptidyl-prolyl cis-trans isomerase 3.10E+08 1.32E+08 2.35 0.038
Ppn1 Dual endo- and exopolyphosphatase 1.06E+07 4.54E+06 2.35 0.017
Sen1 ATP-dependent 5' to 3' RNA/DNA and DNA helicase 6.88E+06 3.00E+06 2.29 0.021
Rgc1 Putative regulator of the Fps1p glycerol channel 1.17E+07 5.12E+06 2.28 0.034
Chs1 Chitin synthase I 6.31E+05 2.77E+05 2.28 0.045
Chd1 Nucleosome remodeling factor 1.66E+07 7.28E+06 2.27 0.005
Pil1 Primary component of eisosomes 7.23E+08 3.19E+08 2.27 0.006
Sin3 Component of the Sin3p-Rpd3p histone deacetylase complex 5.13E+06 2.27E+06 2.26 0.004
Pet127 Protein with a role in 5'-end processing of mitochondrial RNAs 4.60E+06 2.05E+06 2.24 0.030
Nqm1 Transaldolase of unknown function 1.92E+06 8.61E+05 2.23 0.001
Ssa4 Heat shock protein 3.06E+06 1.38E+06 2.22 0.020
Reb1 RNA polymerase I enhancer binding protein 8.98E+06 4.05E+06 2.22 0.015
Mss116 Mitochondrial transcription elongation factor 1.80E+07 8.11E+06 2.22 0.020
Mpd1 Member of the protein disulfide isomerase (PDI) family 3.95E+07 1.79E+07 2.21 0.023
Ino80 ATPase and nucleosome spacing factor 1.91E+07 8.65E+06 2.21 0.007
Mpp10 Component of the SSU processome and 90S preribosome 1.81E+06 8.24E+05 2.20 0.013
Spt5 Regulator of Pol I and Pol II transcription and pre-mRNA processing 1.08E+07 4.92E+06 2.19 0.048
Nop1 Nucleolar component of the small subunit processome complex 2.78E+08 1.27E+08 2.18 0.015
Noc2 Protein involved in ribosome biogenesis 3.50E+07 1.60E+07 2.18 0.011
Dss1 3'-5' exoribonuclease 2.58E+06 1.19E+06 2.17 0.001
Slh1 Putative RNA helicase related to Ski2p 1.08E+06 5.02E+05 2.16 0.032
Pmt1 Protein O-mannosyltransferase 1.11E+06 5.24E+05 2.11 0.005
Enp1 Protein associated with U3 and U14 snoRNAs 4.15E+06 1.96E+06 2.11 0.018
Set2 Histone methyltransferase with a role in transcriptional elongation 6.86E+05 3.25E+05 2.11 0.036
Hsp31 Methylglyoxalase that converts methylglyoxal to D-lactate 5.74E+06 2.72E+06 2.11 0.006
Itc1 Subunit of the Isw2p-Itc1p chromatin remodeling complex 1.03E+07 4.88E+06 2.11 0.027
Tfc7 Subunit of RNA polymerase III transcription initiation factor complex 8.07E+06 3.85E+06 2.09 0.001
Nhp2 Nuclear protein essential for function of H/ACA-type snoRNPs 7.79E+07 3.73E+07 2.09 0.011
Table S4 (continued)
Mean Mean T-test
Protein Protein abundance abundance Ratio p-value
Name Function + AICAR - AICAR + vs - AICAR + vs - AICAR
Rqc2 Component of RQC, which mediates nascent chain degradation 1.67E+07 8.01E+06 2.09 0.018
Mdj1 Co-chaperone  stimulating the ATPase activity of  Ssc1p 3.60E+06 1.73E+06 2.08 0.028
Nop58 Protein involved in pre-rRNA processing 1.20E+08 5.78E+07 2.08 0.050
Nop8 Nucleolar protein required for 60S ribosomal subunit biogenesis 9.76E+05 4.74E+05 2.06 0.013
Rpb2 RNA polymerase II second largest subunit B150 7.68E+06 3.73E+06 2.06 0.008
Kog1 Subunit of TORC1 1.45E+06 7.09E+05 2.05 0.007
Yfr006w Putative X-Pro aminopeptidase 8.73E+06 4.26E+06 2.05 0.048
Gcy1 Putative NADP(+) coupled glycerol dehydrogenase 1.61E+06 7.89E+05 2.04 0.021
Top2 Topoisomerase II 4.73E+07 2.33E+07 2.03 0.012
Rvb1 ATP-dependent DNA helicase 7.53E+07 3.72E+07 2.03 0.015
Kre33 Protein required for biogenesis of the small ribosomal subunit 1.61E+07 7.96E+06 2.02 0.008
Tdh1 Glyceraldehyde-3-phosphate dehydrogenase 1.28E+08 6.36E+07 2.02 0.012
Ssf1 Constituent of 66S pre-ribosomal particles 5.36E+06 2.66E+06 2.01 0.047
Tra1 Subunit of SAGA and NuA4 histone acetyltransferase complexes 3.72E+06 1.86E+06 2.00 0.013
Table S5: GO term analyses for  the 92 proteins more abundant  when Kap123 is overexpressed
Fold
Biological process Enrichment p-Value 
Histone exchange 25.27 4.38E-03 2.35852589
Regulation of  chromatin organization 14.15 1.73E-03 2.7619539
Chromatin assembly 9.8 9.26E-04 3.03338901
Histone modification 9.13 5.63E-08 7.24949161
Chromatin organization 6.57 1.37E-13 12.8632794
Transcription, DNA-templated 4.1 1.74E-09 8.75945075
Regulation of gene expression 3.02 2.07E-08 7.68402965
Fold
Cellular component Enrichment p-Value 
NuA4 histone acetyltransferase complex 26.06 8.86E-06 5.05256628
INO80-type complex 19.05 7.35E-05 4.13371266
Swi-SNF-type complex 10.79 1.27E-04 3.89619628
Nuclear chromatin 6.87 2.97E-07 6.52724355
Nuclear chromosome 4.77 5.49E-07 6.26042766
Nucleolus 4.62 1.61E-05 4.79317412
Nuclear lumen 3.87 1.13E-14 13.9469216
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Table S6 : Yeast strains used in this study 
Strain 
Name 
Genotype 
BY4741 MATa his3∆1 leu2∆0 ura3∆0 lys2∆0 
BY4742 MATalpha his3∆1 leu2∆0 ura3∆0 lys2∆0 
Y1162 MATalpha ade16::KanMX4 ade17::KanMX4 his3∆1 leu2∆0 ura3∆0 lys2∆0 
Y2950 MATalpha ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1 leu2∆0 ura3∆0 
Y3655 MATa fum1::LEU2 ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1 leu2∆0 ura3∆0   
Y6986 MATalpha ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1::HIS3-LEU2 leu2∆0 ura3∆0 
Y7321 MATalpha thi3 (S402F) ade16::kanMX4 ade17::kanMX4 ade8::kanMX4 his1::kanMX4 his3 ∆ 1::HIS3-LEU2 leu2∆0 ura3 ∆ 0 
Y8480 MATa ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1 leu2∆0 ura3∆0   
Y8908 MATa ade3::KanMX4 ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1 leu2∆0 ura3∆0   
Y9082 MATa bre1:: KanMX4 ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1 leu2∆0 ura3∆0   
Y9168 MATalpha set1::KanMX4 ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1 leu2∆0 ura3∆0 met15∆0  
Y9479 MATalpha swd1::KanMX4 ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1 leu2∆0 ura3∆0 lys2∆0 
Y9480 MATalpha swd3::KanMX4 ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1 leu2∆0 ura3∆0 lys2∆0 
Y9623 MATalpha kap123::KanMX4 ade16::KanMX4 ade17::KanMX4 his3∆1 leu2∆0 ura3∆0 
Y9715 MATalpha ynk1::KanMX4 ade16::KanMX4 ade17::KanMX4 his3∆1 leu2∆0 ura3∆0 
Y10846 MATa ade16::KanMX4 ade17::KanMX4 aah1::KanMX4 his3∆1 leu2∆0 ura3∆0   
Y10867 MATa snf4::KanMX4 ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1 leu2∆0 ura3∆0   
Y10422 MATalpha ade13::URA3 ade16::KanMX4 ade17::KanMX4 ade8::KanMX4 his1::KanMX4 his3∆1 leu2∆0 ura3∆0   
 
Table S7: Plasmids used in this study 
 
Plasmid Name Relevant criteria Source 
pCM189 tetO7 promoter CEN ARS URA3 AmpR (1) 
pET15b His6-Tag AmpR #69661-3 Merck 
pGFP-C-Fus pMET25-GFP URA3 CEN (2) 
pRRLSin-PGK-IRES-ZsGreen-WPRE pPGK-EGFP URA3 AmpR #12252 Addgene  
pFL44L 2 µ URA3 AmpR F. Lacroute 
YepLac195 2 µ URA3 AmpR (3) 
P4919 URA6 in YepLac195 This study 
P4979 PAN3 URA6 in pFL44L This study 
P4983 KAP123 in YepLac195 This study 
P5055 Myc-KAP123 in pCM189 This study 
P5486 URA6 in pRRLSin-PGK-IRES-ZsGreen-WPRE This study 
P5653 RPL25-NSL in pGFP-C-Fus This study 
 
References cited: 
(1) Garí E, Piedrafita L, Aldea M, Herrero E. (1997) A set of vectors with a tetracycline-regulatable promoter 
system for modulated gene expression in Saccharomyces cerevisiae. Yeast. 13: 837–848. 
(2) Niedenthal RK, Riles L, Johnston M, Hegemann JH. (1996) Green fluorescent protein as a marker for gene 
expression and subcellular localization in budding yeast. Yeast. 12(8):773-86. 
(3) Gietz RD, Sugino A. (1988) New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized 
yeast genes lacking six-base pair restriction sites. Gene. 74(2):527-34. 
Table S8: Mass spectrometry acquisition parameters 
 
 
 LTQ LTQ-Orbitrap XL Q-Exactive 
MS mass range 300-1700 300-1700 300-2000 
MS resolution - 70000 70000 
AGC target 3.104 in 10 ms 5.105 in 500 ms 106 in 100 ms 
MS/MS strategy TOP 3 TOP 6 TOP 15 
MS/MS mode CID CID HCD 
MS/MS resolution - - 35000 
MS² AGC target 104 in 100 ms 104 in 50 ms 105 in 120 ms 
Ion isolation window 2 m/z 3 m/z 3 m/z 
Normalized collision energy 35 35 25 
Charge state selection 2-4+ 2-3 2-3 
Dynamix exclusion duration 20 s 30 s 30 s 
Sequest MS mass tolerance 1.4 Da 10 ppm 10 ppm 
Sequest MS² mass tolerance 0.6 Da 0.6 Da 0.02 Da 
 
 
